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CHAPTER 1 
 
Natural Products and Drug Discovery 
 
For thousands of years, natural products have played an important role 
throughout the world in treating and preventing human diseases. Natural 
product medicines used in different countries and Medical Systems have come 
from various source materials including terrestrial plants, terrestrial 
microorganisms, marine organisms, and terrestrial vertebrates and 
invertebrates. 
The value of natural products in this regard can be assessed using 3 criteria:  
 the rate of introduction of new chemical entities of wide structural 
diversity, including serving as templates for semisynthetic and total 
synthetic modification 
 the number of diseases treated or prevented by these substances 
 their frequency of use in the treatment of disease. 
An analysis of the origin of the drugs developed between 1981 and 2002 
showed that natural products or natural-product derived drugs comprised 28% 
of all new chemical entities (NCEs) launched onto the market. [Newman et al. 
2003] 
Furthermore, 24% of these NCEs are synthetic or natural mimic compounds, 
based on the study of pharmacophores related to natural products. [Newman et 
al. 2000] 
This combined percentage (52% of all NCEs) suggests that natural products are 
important sources for new drugs and are also good lead compounds suitable for 
further modification during drug development. The large proportion of natural 
products in drug discovery has stemmed from the diverse structures and the 
intricate carbon skeletons of natural products. 
Since secondary metabolites from natural sources have been elaborated within 
living systems, they are often perceived as showing more “drug-likeness and 
biological friendliness than totally synthetic molecules” [Koehn et al. 2005] 
  5 
making them good candidates for further drug development. [Balunas et al. 
2005] [Drahl et al. 2005] 
The investigation of the pharmacological activity of vegetal extracts represents 
the start point for the research of active molecules in the vegetal mixture and 
for the clinical investigation of the effectiveness of the whole extract which 
may administered as a food supplement. 
Scrutiny of medical indications by source of compounds has demonstrated that 
natural products and related drugs are used to treat 87% of all categorized 
human diseases, including as antibacterial, anticancer, anticoagulant, 
antiparasitic, and immunosuppressant agents, among others. [Newman et al. 
2003] 
In the case of antibacterial agents, natural products have made signifi cant 
contributions as either direct treatments or templates for synthetic modifi 
cation. Of the 90 drugs of that type that became commercially available in the 
nited States or were approved worldwide from 1982 to 2002, ~79% can be 
traced to a natural product origin. [Newman et al. 2003] 
In the Unites States, 84 of a representative 150 prescription drugs are 
represented by natural products, including, predominantly, as anti-
allergy/pulmonary/respiratory agents, analgesics, cardiovascular drugs, and for 
infectious diseases. [Newman et al. 2003] 
Furthermore, natural products or related substances accounted for 40%, 24%, 
and 26%, respectively, of the top 35 worldwide ethical drug sales from 2000, 
2001, and 2002. [Butler 2004] 
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Fig. 1: Drug Discovery from vegetal extracts 
 
The process leading to the discovery of new active compounds from vegetal 
extracts can involve  
 the evaluation of the pharmacological activity of the whole extract, 
obtained in the same way it is done in Folk Medicine 
 Fractionation of the extract 
 Evaluation of the pharmacological activity of the different fractions and 
identification of the most active fraction 
 Further Fractionation of the active fraction and identification of the 
active compound(s) 
 Synthesis of analogs through modern medicinal chemistry-based 
molecular modification 
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The drug discovery process presupposes the knowledge of the Traditional 
Medicine in order to identify the vegetal extracts we can consider to give rise 
to the Research of new active compounds from natural extracts.  
 
Traditional Chinese Medicine and Ayurvedic 
Medicine: different approaches 
 
The two most prevalent forms of traditional medicine (TM) in Asia are the 
traditional Chinese medicine (TCM) and the traditional Indian medicine 
(represented by Ayurveda). 
Over the years, TCM and Ayurveda have diffused all over the world. The two 
medical traditions represent a larger and larger part in the global market, 
presumably due to the rising interest not only among the consumers but also 
among the Medical Doctors. [Patwardhan et al. 2005] 
The historical, cultural and social foundations of the Asian states are based on 
the three main philosophical traditions, represented by the Vedic philosophy 
(giving rise to Ayurveda), Taoism (giving rise to TCM) and Confucianism. 
Ayurveda and the Vedic philosophy represent the main phylosophies in the 
West Asian countries including India, Pakistan, Tibet, whereas TCM is the 
main philosophy in the East Asian countries including China, Korea, Japan, 
Vietnam. [Patwardhan et al. 2005] 
Another Traditional Medicine, derived from TCM, is the Korean medicine 
(TKM). The Sasang constitutional medicine (SCM), first introduced by Jema 
Lee in 1894, belongs the TKM which shares the same principles of the TCM. 
[Song 2005] 
Many different aspects in Ayurveda, TCM and SCM are common. 
SCM, TCM and Ayurveda show the same basic holistic approach to healthcare 
which  presupposes that the subject is considered as a whole entity. According 
to these medical traditions, pathological conditions are the results of single or 
combined disturbances/imbalances on the physical, psychological, social and 
spiritual levels. Medical interventions therefore necessarily take into account 
the multifaceted and complex relationship between the spirit, mind and body, 
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and the aim of therapy is not the elimination of the isolated disease or symptom 
but the treatment of the body as a whole. [Zollman et al. 1999] 
The diagnosis, in Traditional Medicine, is based on the subjective examination, 
consisting of observing, listening, inquiring and palpating, of the patients by 
the Medical Doctors and the Therapy is exerted through a range of therapeutic 
modalities such as herbal medication, acupunctural therapy and manual 
therapy.  
In general, the herbal remedies used in this kind of Medicine, are a mixture of 
different vegetal extracts and the therapeutic effect is the result of the 
synergistic action of all the administered plant extracts which aim to restore the 
internal body imbalance. [Kim et al. 2009] [Khan et al. 2001] 
The Approach belonging to the so called “holistic Medicine” involves the 
Examination of the patient who has to be treated as a whole, complex organism 
and the therapy can not include the same substances for the cure of a Disease, 
while it provides the substances able to cure the patient belonging to a 
prevalent constitution who develops a Disease. The Concept is to cure the 
Person, not the Disease. In other words, the same Disease may be treated with 
different herbal formulae or therapeutic methods depending on the 
characteristics of the patient.  
Individuals are born with different traits and characteristics. SCM and 
Ayurveda emphasize the importance of variation in the constitutional makeup 
among individuals. These two medical traditions are based on the recognition 
and acceptance of the inherent constitutional differences between individuals, a 
concept that is central in SCM and Ayurvedic therapeutics. [Song 2005] 
[Sharma et al. 2007] 
In contrast, the pathological presentation of the patient at the time of 
examination is the foremost consideration in TCM, whereas the other factors 
(such as the progression of disease, family history and congenital conditions) 
are taken into consideration but only in a secondary capacity. Although TCM, 
SCM and Ayurveda show the same qualities of holistic medicine in wich they 
all treat an individual as a whole, they each start off from different viewpoints. 
TCM therapy begins with the evaluation and differentiation of syndrome (or 
the identification of disease patterns) [Tang et al. 2008], whereas the 
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constitutional typing and determination of the constitutional proclivity 
represent the first steps in SCM and Ayurveda therapy. Whereas the TCM 
therapy uses reducing and tonifying methods to redeem the external pathogenic 
factors such as blood stasis and qi deficiency, the therapeutic goal in SCM lies 
in the restoration and minimization of the imbalance in the quadrifocal organ 
scheme. In other words, although the therapeutic methods and materials may 
overlap, TCM and SCM use them for completely different reasons from 
completely different rationales. Ayurveda assigns an individual into one of the 
seven main constitutional types, or prakriti, based on the inherent imbalance of 
the three energy forces, or dosha, that are each called Vatta, Pitta and Kapha. 
SCM is rooted in the quaternity central to the Sasang philosophy and classifies 
the constitutional makeup of an individual into one of the four constitutional 
types namely, the Taeyang type (TY), the Soyang type (SY), the Taeeum type 
(TE) and the Soeum type (SE). In SCM, the inherent proclivity in the 
constitutional imbalances exacerbates the weaknesses of the constitutional 
type, leading to specific patterns in susceptibility to particular pathologies. 
SCM therapy, therefore, is focused on minimizing these weaknesses in order to 
restore the internal balance. [Song 2005] [Sharma et al. 2007] 
In SCM, the concepts of physiology and pathology are based on the 
quadrifocal scheme or quaternity which differs from  the bifocal scheme or 
dichotomy of the Yin-Yang theory, representing the philosophical basis of 
TCM. The model explaining the internal organ structure in SCM is called 
“seesaw” model. In this system, the SE and SY types correspond to the spleen-
kidney seesaw, where the spleen is responsible for the intake of food and the 
kidney for the discharge of waste products. A strong kidney system and a weak 
spleen system are typical characteristics of the SE type, whereas a strong 
spleen system and a weak kidney system belong tipically to the SY type. The 
TE type has a strong liver system and a weak lung system, whereas the TY 
type is characterized by a strong lung system and a weak liver system [Song 
2005] [Kim et al. 2009] 
The concept of lung, liver, spleen and kidney in SCM was originally derived 
from the TCM theories but later evolved into a different physiopathological 
concept. 
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According to SCM, the weakness of each constitutional type corresponds to the 
preservative energy related to the most hypoactive viscera which represents the 
essential energy necessary to maintain homeostasis. The clearing Yin energy, 
the warming Yang energy, the dispersive energy and the accumulative energy 
are the requisite energies for the SE, SY, TE and TY types, respectively. The 
main therapeutic goals in SCM are the reinforcement and the preservation of 
the requisite energies. 
The Ying Yang theory represents the base of the TCM pathology, even if the 
main theory is represented by five elemental phases theory. The five elements, 
which are wood, fire, earth, metal and water, exist in a mutual relationship 
between them. The restoration of the balance among these elements is the aim 
of the TCM. A five elements theory is also present in the Ayurvedic 
physiology and pathology [Tirtha 2005], even if this concept in Ayurveda 
differs from TCM. Infact, the five elements in the Ayurvedic theory are 
considered to have a sequentially fortifying relationship only,whereas the TCM 
elemental phases interact mutually in assisting and controlling relationships.  
The therapeutic remedies used in Asian TM traditions are, in general, made 
with on botanical sources. The SCM and the TCM use, generally, the same 
herbal remedies, however the basic principles of usage and the underlying 
rationale are completely different. In SCM, the prime consideration concerns 
the identification of the constitutional type of the patient which is a critical step 
for the selection of the medicinal herbs and formulae for treatment. A 
particular  medicinal herb is compatible with only one specific constitutional 
type and can therefore be used for that constitutional type only and be mixed 
with other herbs compatible with that constitutional type only. Use of a 
medicinal herb on an incompatible constitutional type can result in little effect 
or even induce adverse effects. For example, Radix Ginseng, an SE medicinal 
herb, and Radix Rehmanniae Glutinosae, an SY medicinal herb, should not be 
used in combination with each other. Also, a medicinal herb cannot be used 
across different constitutional types, but can be used for different 
symptomatologies or diseases within that constitutional type [Kim et al. 2001 
a] [Kim et al. 2001 b] 
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In contrast, TCMmedicinal herbs are classified according to the therapeutic 
effects of the herb itself, namely, dispersive quality, Yin tonifying quality and 
so forth. Consequently, a particular medicinal herb can be applied to any 
patient afflicted with the same disease or pathology regardless of the 
individual’s constitutional type. For instance, Radix Ginseng is sometimes used 
in combination with Radix Rehmanniae Glutinosae in some TCM formulae 
[Liu et al. 2005]. Ayurvedic and SCM therapeutics are based on constitutional 
approach, and the medicinal herbs are selected or excluded according to their 
compatibility or incompatibility to the constitutional makeup of a given 
individual. Ayurvedic medicinal herbs are distinguished by their effects on the 
three doshas, whereas SCM medicinal herbs are categorized according to their 
effects on the different constitutional types. For instance, Cortex Cinnamomi, a 
commonly used medicinal herb, is described in the Ayurvedic practice as being 
able to repress Vitta and Kapha while enhancing Pitta, whereas in SCM it is 
suggested to be compatible with the SE type and incompatible with the SY 
type. On a slightly different note, the actual specimen ofmedicinal herbs used 
in Ayurveda and SCM are likely to be different from each other due to the 
differences in the regional flora. [Kim et al. 2001 a] [Liu et al. 2005] 
 
Traditional Medicine in the West 
 
Theophrastus (370-285 B.C.), who was a philosopher from Athens and a 
Student of Aristotle, is considered the founder of the West botany. The 
Botanical Theophrastus’ works, Historia plantarum and Causae plantarum, 
cover almost every part of the modern Botany, including morphology, 
physiology, taxonomy and pharmacognosy. These texts represent a 
significative part of the ancient knowledge in the field of botany. Ippocrate 
Kos, a physician of the ancient Greek who used methods of cure which have 
been used up to the Romanian world and to the Middle Ages, was the first to 
classify, systematically, 300 plants species. One of the oldest botanical gardens 
is the garden of Alexandria of Egypt (from the fourth century B.C., under the 
Ptolemies). Another important botanical garden is the garden established in 
Athens, around 340 B.C., by the will of Aristotle with the aim of study and 
research about plants.  
  12 
In the Romanian times, very important works about pharmacognosy and 
pharmacotherapy are written. In these works, the drugs are no longer reported 
as a simple list or as an appendix to the disease (like in the writings of 
Hippocrates), but they are described by systematic and descriptive criteria 
which include their dosage, their method of administration, their adverse 
effects. 
Since the first century A.C., in Rome, it was common practice to cultivate 
gardens with medicinal plants. Among the most important works of this period, 
we must remember the De medicina of Celsus (18 AD); the important work in 
5 volumes of Dioscorides Pedanius Anazarbeo (I century AD), De Materia 
Medica, which represent all the medical knowledge at the time, including that 
relating to the medicinal properties of plants. This encyclopedia was 
considered a great authority throughout the Middle Ages, almost to the 
sixteenth century. For the first time, the plants are not reported in the 
alphabetical order, but according to their affinities. In these works, the 
descriptions are often influenced by philosophical, magical and astrological 
conceptions.  
Another important physician of the Roman time is Claudius Galen (190-291) 
who cataloged the drugs according to the heat (or mood), allowing the choice 
of drug with this parameter for each disease (Methodus medendi). After the fall 
of the Roman Empire and the barbarian invasions, the scientific knowledge 
was preserved in the monasteries or developed by the Arabian world.  
The modern phytotherapy origins in the Renaissance period with the birth of 
the first medical schools and universities (second medical school of Salerno. 
XI-XIII, University of Montpellier sec. XII). Paracelsus, the Medici, the Este, 
Leonardo da Vinci encouraged the research. During this period, there has been 
a shift away from empiricism of the alchemists in favor of a scientific testing 
with more sophisticated means of investigation. This allowed Carl Linnaeus 
(1707-1778 AD) to develop the systematic study of plants and to establish 
strict rules for the cultivation and harvesting of medicinal herbs. In the period 
from late 1700 to early 1800, in the field of Medicine many important 
discoveries occurred.  
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In the nineteenth century medical science has made an exponential progress, 
accompanied by surprising novelty in the field of chemistry: Wöhler 1800-
1882, a student of Berzelius, obtained urea in the laboratory while he was 
trying to prepare the ammonium thiocyanate. After this first synthesis, 
Hermann Kolbe, a professor of chemistry at the University of Narburg (1818-
1884), student of Wöhler, succeeds in the synthesis of acetic acid. In 1859, he 
discovered the chemical structure of salicylic acid and he was able to 
synthesize the molecule in the laboratory. The French chemist Marcelin 
Berthelot (1827-1907) could synthesize dozens of organic chemicals such as 
methyl alcohol, ethyl alcohol, methane, benzene and acetylene. From the early 
years of the '900, with the development of chemical technology and science, 
there has been a shift away from medicine herbal medicine and a growing 
attention to synthetic drugs, with the support of the first chemical-
pharmaceutical companies that arose in those years. In the second half of the 
900 medicine in Europe, called classic, is the only one to be in common use. 
However, in recent years, there has been a significant turnaround, with the 
return to herbal medicine and alternative medicine in general: there are now 
realities intimately related, traditional medicine and alternative medicine. 
Today we are able to separate the different active ingredients contained in plant 
extracts and to investigate which component is attributable to the 
pharmacological effect of the extract studied could, in this way to combine the 
ancient with the modern science, for the continuous search for new therapeutic 
molecules that the natural world offers us. 
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CHAPTER 2 
 
Castanea Sativa Mill. 
 
 
 
Fig. 2: Castanea sativa Mill. 
 
Chestnut is a genus gathering eight or nine species of deciduous trees and 
shrubs, belonging to the Family of Fagaceae. The origins of this genus are 
represented by the temperate regions of the northern hemisphere. There are 
four main species referred as European chestnut (Castanea sativa Mill), 
Chinese chestnut (Castanea mollissima), Japanese chestnut (Castanea crenata), 
American chestnuts gathering dentata (American chestnut - Eastern states), 
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Castanea pumila (American- or Allegheny chinkapin, also known as "dwarf 
chestnut" - Eastern states), Castanea alnifolia (Southern states), Castanea 
ashei (Southern states), Castanea floridana (Southern states) and Castanea 
paupispina (Southern states). [Artemas Ward 1911] [Mencarelli 2001] 
 
 
 
Fig. 3: Castanea sativa Mill Distribution 
 
This work is focused on Castanea sativa Mill.  
The sweet chestnut tree is a native of southern Europe, the Caucasus, Asia 
Minor and northern Africa. The young branches are reddish brown with light 
lenticels (pores in the bark), the leaves are elongated, feather-shaped and 
serrated. dark green on top and a lighter green underneath. The seeds grow in a 
green-brown cupule or outer shell with long spiky hairs which can be up to 5 
centimetres long. Depending on the variety, one cupule may contain one to 
three seeds, which become brown when ripe, in October or November. The 
bark of the tree takes on a grey hue with age and is grooved and typically 
twisted. The chestnut wood is characterized by early formation of heartwood, 
and the sapwood is very thin. The heartwood is brown while the sapwood is 
light gray. A typical characteristic of the sweet chestnut is the large pores of 
the springwood that are clearly visible on the end-grain. They are also apparent 
as ridges in the long-section. The pores of the summerwood are much finer and 
barely visible. The longitudinal section is either clearly striped (radial cut) or 
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with a wavy grain (cross cut). A characteristic of chestnut wood is the lack of 
wood rays on the end-grain. 
The sweet chestnut blooms in June or July, its blossom consisting of the male 
catkins, which are long, yellowish anthers, and the reddish females 
inflorescences.  
The sweet chestnut, representing the most characteristic tree of southern 
Europe together with olive and fig, has always been of great economic 
importance especially in Italy, France and Switzerland.  
It has been cultivated on a large scale for its nourishing as well for its wood.  
The wood and the bark of sweet chestnut contain a lot of tannins, so in Europe 
it has been used for the colouring and tanning of hides.  
The tannin content of a mature sweet chestnut wood (a tree at least thirty years 
old) in Southern Europe is 10 to 13 percent higher than that of the chestnut 
trees in the north. Italy has the largest commercial production of tannin. 
The wood is very durable and serves, as the French say, literally du berceau au  
cercueil, from the cradle to the grave” (Coffin). It is used for poles (for 
instance, in the Kentish hop gardens), fence posts, railway sleepers, beams, 
garden furniture and, on account of being waterproof, for making wine barrels. 
In addition, it is used in order to produce castanets, mostly cut from chestnut 
wood, as their name indicates.  
The Sweet Chestnut Wood Extract is, used in Folk Medicine, as an antidote 
against the bite of a rabid dog, as well as against dysentery, coughing and 
vomiting, and baldness. In a Swedish herbal the sweet chestnut is also 
mentioned as a remedy for whooping cough.  
In folk medicine, the water extract of the bark is used in order to cure diarrhoea 
of different origin. In order to verify the existence of an activity toward gut 
motility of a Natural Extract of Chestnut Wood extract rich in ellagitannins, 
named ENC, its pharmacological activities have been tested in the 
experimental models described in the following paragraph. 
In addition since ENC shows antimicrobial activities toward pathologic gastro-
intestinal agents, a potential antispasmodic activity may be useful to treat 
diarrhoea, which represents a world-wide health trouble, as described in the 
following paragraph. 
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CHAPTER 3 
 
ENC (Natural Extract of Chestnut Wood) 
 
Purified ENC (supplied by SilvaTeam, San Michele di Mondovì, Italy) 
isobtained by low pressure heating treatment. The water-soluble fraction is 
retained and subsequently dehydrated. The fine brown powder (92-95% dry 
matter) contains 77% of pure tannin on a dry matter basis. The chemical 
composition of the ENC batch used in the experiments was as follows: water, 
2.9%; tannin, 77.8%; non-tannin, 17.7% (oligosaccharides, salts, vegetable 
resins, and gums coming from the hydrolysis process of chestnut wood); 
insoluble, 1.6%; crude fibers, 0.24%; ash, 1.7%. The tannin percentage was 
obtained by gravimetrie analysis of vegetable tanning agents by using the filler 
Freiberg-Hide powder method. [Kuntzel 1954] 
 
3.1 Chemical characterization of ENC 
Before starting the evaluation of the biological activity of the extract,  the 
analysis in order to identify the main organic compounds present in ENC has 
been exerted.  
The total phenol (TP) content content of tannin of chestnut extract was firstly 
determined by Folin-Ciocalteau method. [Singleton et al. 1965] This 
colorimetric test was used for a preliminary characterization of the extract, in 
fact, as each phenolic compound produces a different colour yield per unit 
mass in colorimetric assay, it is very disputable to choose a single phenol as 
reference standard for the total phenol calculation. [Mueller-Harvey 2001] The 
molar absorptivity of the standard chosen is peculiar and dependent on the 
number and the kind of chromophores present in the molecule, and on the 
solvent used for the detection. This peculiarity should be considered during the 
spectrophotometric quantization of total phenols, because it determines the 
intrinsic approximation of such analytical technique. [Pelillo et al. 2004] 
Basing on literature data [De Vasconcelos et al. 2010] [Scalbert et al. 1989] 
[Vázquez et al. 2008] [Živković et al. 2010], gallic acid was selected as 
reference standard for a TP content by Folin-Ciocalteau spectrophotometric 
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method. TP content of the examined chestnut bark extract was 54.9 % of dry 
weight (g GAE/100 g of extract). 
A quail-quantitative analysis of the extract and was realized by HPLC. 
Tentative identification of tannins and phenolic compounds was made on the 
basis of retention time, molecular weight, spectroscopic properties and MS 
fragmentation characteristics (ESI negative mode), as described in Comandini 
et al. [Comandini et al. 2011] Table 1 reports the compounds characterized in 
chestnut bark extract, including ellagic acid, gallic acid and 4 ellagitannins 
(vescalin, castalin, vescalgin and castalgin). 
 
Table 1 Amounts of separated tannins and phenolic compounds in chestnut bark extract, 
expressed as g EAE /100 g and as g GAE/100g. 
Compound g EAE/100 ga  g GAE/100ga  
Vescalin 0.56 ± 0.02  1.18± 0.06  
Castalin 0.69 ± 0.02  1.47± 0.06  
Gallic acid 1.25 ± 0.04  3.68± 0.12  
Vescalgin 2.31 ± 0.05  5.01± 0.11  
Castalgin 2.26 ± 0.07  4.96± 0.08  
Ellagic acid 1.70 ± 0.05  3.64± 0.10  
Other compounds 1.92 ± 0.04  4.07± 0.04  
Total 10.69 ± 0.28  24.01± 0.57  
a Values are means ± S.D. (n=3). 
 
The three major components were vescalgin, castalgin and ellagic acid. Other 
minor compounds (quantified as Other compounds in Table 1), previously 
reported in chestnut bark [Lampire et al. 1998] [Canas et al. 1999] detected in 
trace levels are: 5-O galloylhamamelose, (3 ,5-dimethoxy-4 -hydroxyphenol)-
1-o-β -D-(6'-o-galloyl)-glucoside isomer, m-digallic acid, kurigalin isomer and 
chestanin. The class “Other compounds” also included a not identified 
ellagitannin, which eluted between vescalgin and castalgin in the 
chromatographic trace, and represented 14.6% of the total concentration of the 
separated compounds. 
The total concentration of ellagitannins and phenol compounds identified, 
expressed in ellagic acid, was about 10.69 g GAE/100 g. 
Vescalagin and castalagin belongs to the class of ellagitannins and in particular 
to the Okuda’s type II+ ellagitannins. 
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Fig. 4: Chemical structures of thr 4 main ellagitannins present in ENC   
 
3.2. General Structures of Ellagitannins. 
Ellagitannins represent one of the major classes of polyphenolic natural 
products and derive from the secondary metabolism of dicotyledonous plant 
species of the Angiospermae. [Quideau 2004] [Quideau 2006] [Quideau et al. 
2011] Their general chemical structures consist, basically, of a central sugar 
core, in general D-glucopyranose, to which are esterified gallic acid (1, i.e., 
3,4,5-trihydroxybenzoic acid;fig. ) units that are further connected together 
through C–C biaryl and C–O diaryl ether bonds as a result of intra- and 
intermolecular phenolic oxidative coupling processes. [Haslam and Cai 1994] 
[Quideau and Feldman 1996] [Khanbabaee and van Ree 2001] To date, thanks 
to the work of more than 50 years of investigations, from the seminal work of 
the German chemists Schmidt and Mayer to the outstanding contributions from 
the Japanese groups of Okuda, Yoshida, Nishioka and Kouno, about 1000 
members of this subclass of so-called hydrolysable tannins (vide infra) have 
been isolated from different plant sources and completely characterised, thus 
determining the biggest group of known molecules belonging to the class of 
tannins. [Schmidt and Mayer 1956] [Okuda et al. 1995] [Okuda 2005] The 
number of about 1000 several molecular entities is very surprising when 
observing that they all plausibly are produced by a single precursor 3 [i.e., 
penta-O-galloyl-b-D-glucopyranose (β-PGG), see Scheme 1, Section 2], which 
is synthesized from two simple building blocks, represented by D-
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glucopyranose and gallic acid. [Quideau 2004] A so evident structural diversity 
is the result of different various chemical reactions which, initially,  involve 
oxidative (dehydrogenative) C–C coupling of galloyl groups on the 
glucopyranose core in either its 4C1- or its 1C4-conformation. 
Further dehydrogenative transformations of galloyl and galloyl-derived groups 
are responsible for the induction of the hydration, decarboxylation, carbo- and 
oxocyclization, ring opening or ring contraction events, as well as of 
oligomerization processes via oxidative C–O coupling reactions. Hydrolytic 
cleavage of galloyl and galloyl-derived groups, glucopyranose ring opening 
(often followed by C-aryl glucosidation), additional galloylations, 
oligomerizing condensation reactions, as well as other condensation and 
conjugation events with other entities such as simple gallic acid derivatives, 
ascorbic acid, [Tanaka 2009] monosaccharides and flavanoids further expand 
the structural diversity and complexity of the ellagitannin family. 
 
3.3 Different Groups of ellagitannins 
3.3.1 Monomeric ellagitannins 
The variety of ellagitannin structures is very large and its subdivision into 
different categories following a logically ordered manner has been carried out 
by different authors. 
Haslam made a first subdivision of the two known subclasses of hydrolysable 
tannins (i.e., gallotannins and ellagitannins) into three groups: [Haslam 1982] 
 group A, corresponding to the gallotannins with a core of β-penta-O-
galloyl-D-glucopyranose (β-PGG, 3) which is linked to several other 
galloyl ester groups further linked in depside fashion,15 as shown in 
Scheme 1 by the typical hexagalloylglucose 4 (i.e., 3-O-digalloyl-
1,2,4,6-tetra-Ogalloyl-b-D-glucopyranose).  
 group B, characterized by the presence of two C–C-coupled galloyl 
ester groups at the 2,3- and/or 4,6-positions of a 4C1-glucopyranose 
core such as tellimagrandins I (5b) and II (5a). The 6,60-dicarbonyl-
2,20,3,30,4,40-hexahydroxybiphenyl group, in general, represents the 
hexahydroxydiphenoyl (HHDP) unit, which is the structural 
characteristic defining hydrolysable tannins as ellagitannins. 
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Ellagitannins undergo hydrolytic reactions determining the release of 
HHDP units which are inevitably converted into the bislactone ellagic 
acid giving the name to these structures.  
 
 
 
Fig. 5: Biosynthesis and classification of the different hydrolysable tannins (gallotannins and 
ellagitannins). 
 
 Haslam’s group C is represented by ellagitannins with  HHDP units 
connected to the 1,6-, 2,4- and/or 3,6-positions of the D-glucopyranose 
ring in its least thermodynamically favored 1C4-conformation, as 
exemplified by the structure of geraniin (7, Figure 5). [Haddock 1982] 
 
These HHDP units show an axial chirality (i.e., atropisomerism).  
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In group B ellagitannins, these chiral biaryl units are found almost exclusively 
in the S-configuration, whereas ellagitannins of group C show both R- and S-
configurations. [Quideau and Feldman 1996] 
The HHDP bisester group undergoes a further oxidation leading to formation 
of the so-called hehydrohexahydroxydiphenoyl (DHHDP) unit, which 
isomerizes into an equilibrium mixture of hydrated five- and six-membered 
hemiacetalic rings in aqueous media. This additional oxidative metabolism 
regards, almost exclusively, the group C ellagitannins, so named 
‘dehydroellagitannins’, such as geraniin (7, Fig. 5). there is a clear exception, 
represented by  isoterchebin (8, Fig. 6), characterized by a DHHDP unit 
bridging the 4,6-positions of a D-glucopyranose ring in its 4C1-conformation. 
[Okuda 1981] 
 
 
Fig. 6: Examples of ellagitannins featuring a DHHDP- or a DHHDPderived ester unit. 
 
The DHHDP unit, consisting of a cyclohexenetrione C–C-bound to a 
pyrogallol motif, represents the site at which additional chemical reactivities 
are present, determining the origin of different other transformations producing 
various other types of monomeric ellagitannins. One example is represented by 
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chebulagic acid (9, Fig. 6) showing the DHHDP-derived chebuloyl unit 
esterified to the 2,4-positions of a 1C4-glucopyranose core, [Yoshida 1980] 
and ascorgeraniin (10, also known as elaeocarpusin), representing an example 
of an ellagitannin deriving from a condensation reaction between ascorbic acid 
and the DHHDP unit of geraniin (7). [Okuda 1986] [Tanaka 1986] 
 
 
 
Fig. 7 Examples of Okuda’s type II and type IV ellagitannins. 
 
More recently, the old classification has been reviewed by Okuda and co-
workers who  proposed four main types of hydrolysable tannins basing on the 
oxidation level of their galloyl ester groups.[Okuda 2000] In this classification, 
which has been elaborated basing on a plausible progressive biogenetic 
  24 
elaboration of hydrolysable tannins, first hypothesised by Schmidt and Mayer 
in 1956, gallotannins are defined as type I hydrolysable tannins. Type II 
includes the ellagitannins with a HHDP unit, involving, for example,the 
monomeric tellimagrandins II (5a) and I (5b) (Fig. 5), casuarictin (11a), 
pedunculagin (11b) and potentillin (11c) (Fig. 7), [Okuda 1982] [Yoshida 
1983] and type III those with the DHHDP unit (i.e., dehydroellagitannins), 
such as geraniin (7, Fig 5). 
As regards ellagitannins whose  DHHDP unit undergoes additional 
transformations, such as the aforementioned chebulagic acid (9) and 
ascorgeraniin (10, Fig. 1), these structures form the type IV group.Two 
examples out of a large series of ester units derived from the parent DHHDP 
unit are represented by the chebuloyl and elaeocarpusoyl ester groups.13 Many 
other DHHDP-derived units exist. 
These include (inter alia) phyllanthusiins A–C (12a–c), repandusinic acid A 
(12d), [Saijo 1989] [Yoshida 1992] and putranjivain A (12e), [Lin 1990] in 
which 2,4-DHHDP-derived unit is the result of the decarboxylation of the 
elaeocarpusoyl unit of ascorgeraniin (10). [Tanaka 2009] These ellagitannins 
are included into Okuda’s type IV hydrolysable tannins group (Fig. 2). 
In this classification many monomeric ellagitannins, whose structures deriving 
from chemical transformations other than those strictly mediated by oxidative 
processes, are excluded. 
In this vein, some important structural modifications regard the opening of the 
D-glucopyranose core, the formation of C-aryl glucosidic bonds (vide infra) 
and condensation reactions then occurring at the glucose C-1 locus (see Section 
7). 
The steps involved in the biosynthesis of ellagitannins from their precursor, 
penta-O-galloyl-b-D-glucopyranose (β-PGG, 3, Fig 5), are just today starting to 
be comprehended, in particular thanks to the work exerted by Gross and co-
workers. [Gross 1992] [Gross 1999] [Niemetz and Gross 2003a] [Niemetz and 
Gross 2003b] 
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Fig. 8. Examples of Okuda’s type II+, type III+ and type IV+ ellagitannins. 
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A β-pentagalloylglucopyranose-oxidizing enzyme favours the formation of the 
4,6-HHDP-containing tellimagrandin II (5a) (Niemetz R., Schilling G. and 
Gross G. G., Chem. Commun., 2001, 35–36) and a different laccase-type 
phenol oxidase catalyzes the dimerization of 5a into the m-DOG-type dimer, 
cornusiin E (26, Fig. 5), through the induction of the formation of a so-called 
valoneoyl-type diaryl ether bridge between the 2-galloyl group of one 
monomer and the 4,6-HHDP unit of the other monomer. [Niemetz and Gross 
2003a] [Niemetz and Gross 2003b] Because these ellagitannins share the 
characteristic structural features with the primary types II–IV, these structures 
have been classified into types II+–IV+.22 Type II+ mainly includes HHDP-
bearing C-glucosidic ellagitannins, such as stachyurin (13) and casuarinin (14) 
and their 5-O-desgalloylated variants 15 and 16, but also 
nonahydroxyterphenoyl (NHTP)-containing analogs such as vescalagin (17) 
and castalagin (18) (Fig. 8). 
Flavanoid hybrids (i.e., flavano-ellagitannins, often globally referred to as 
complex tannins), including, among others, stenophyllanins A/B (19a/20a) and 
camelliatannins A/B (19b/20b), resulting from condensation reactions with the 
flavan-3-ol catechin or epicatechin at the C-1 center of their open-chain 
glucose core, belong to this type II+ subclass, too (Fig. 8). 
Dehydroellagitannins showing moieties which are the result of a diaryl ether 
linkage with another phenolic or polyphenolic unit are included into the type 
III+ group. 
Mallotusinic acid (21, Fig. 8), with a valoneoyl group (see Fig. 5 in Section 
2.2), linked to the 3,6-positions of a 2,4-DHHDP-bearing 1C4-glucopyranose 
core, constitutes a representative example of this class. [Okuda 1978] [Okuda 
1980] 
Transformed dehydroellagitannins with moieties deriving from a C–C linkage 
with another phenolic or polyphenolic unit belong to the type IV+ group. One 
example of a structure belonging to this type resulting from the oxidative 
metabolism of the type II+ camelliatannin A (19b) is represented by the C-
glucosidic epicatechin-containing complex tannin camelliatannin F (22, Fig. 8). 
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3.3.2 Oligomeric ellagitannins 
 
 
Fig. 9 Examples of Okuda’s GOG- and GOGOG-type oligomeric ellagitannins. 
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Basically, types II and II+ oligomerize through various modes based on 
oxidative coupling reactions between free and C–C-coupled galloyl groups 
(i.e., HHDP units) on different glucopyranosic ellagitannins, as well as on 
reactions of condensation occurring at the C-1 center of C-glucosidic 
ellagitannins. In addition, oligomeric structures have been classified into five 
types basing on the nature of the inter-unit linkage between monomers: (i) 
GOG (and GOGOG), (ii) DOG, (iii) GOD, (iv) D(OG)2 and (v) C-glucosidic 
type, for which G ¼ galloyl, O ¼ oxygen and D ¼ HHDP. [Okuda 1993] 
In GOG- and GOGOG-type oligomers, the inter-unit linkages consist of two 
(or three) G units bound together through a diaryl ether bond, as exemplified 
by agrimoniin (23, Fig. 9), [Okuda 1982] which has a meta-GOG type linking 
unit (i.e., one of the oxygen atoms meta-positioned to the carboxyl group-
bearing carbon of one G unit is C-linked to one of the unsubstituted ortho-
positions of the other G unit). In addition, this kind of unit refers to as the 
dehydrodigalloyl (DHDG) unit. Sometimes, isodehydrodigalloyl units (i.e., the 
para-GOG type) are present in some oligomers as those isolated from plant 
species belonging to the family of Tamaricaceae, including Reaumuria hirtella, 
able to produce a dimer, hirtellin C (24), [Yoshida 1993] resulting from a 
double oxidative coupling of two molecules of  tellimagrandin II (5a). This 
double mutual coupling is observed between the O-1-galloyl group of one 
monomer and the O-2-galloyl group of the other monomer and vice versa, but 
one C–O coupling produces the m-GOG type unit, whereas the other 
determines the formation of the more sterically encumbered p-GOG type unit. 
[Yoshida 1993] 
In addition, the same plant species in Tamaricaceae are able to combine the 
same monomeric ellagitannin tellimagrandin II (5a) in different ways through 
the oxidative C–O coupling of galloyl groups, as exemplified by the structure 
of hirtellin B (25). [Yoshida 1991] The two O-2-galloyl groups are bound 
together through a m-GOG type unit, the oxygen-donating O-2-galloyl group 
being similarly linked to the O-1-galloyl group of the same monomeric unit. 
The resulting m-GO-m-GOG type unit is also referred to as the hellinoyl 
group. In addition, the DOG-type units are further classified into their meta and 
para variants. In these units, a HHDP unit is O–C-linked to a G unit. The m-
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DOG type or valoneoyl unit is observed in many oligomeric ellagitannins, 
[Okuda 1993] including, among others, the aforementioned cornusiin E dimer 
(26, Fig. 5), and in some monomeric ellagitannins of type III+ of which 
mallotusinic acid represents an example (21, Fig. 3).  
The dimer oenothein B (27a) [Hatano 1990] present in significant amounts in 
Oenothera and Epilobium species (Onagraceae) and in Lythrum anceps 
(Lythraceae), and its a-monogalloylated variant woodfordin C (27b), 39 
isolated together with 27a from Woodfordia fruticosa (Lythraceae), represent 
significative examples of macrocyclic ellagitannin structures with two 
valoneoyl groups as macroring-forming inter-unit linkages (Fig. 5). 
The m-DOG-type valoneoyl unit represents probably the most often 
encountered inter-unit linkage in ellagitannin oligomerization through 
oxidative coupling processes. In addition, it has been observed in some 
biogenetically intriguing dimers consisting of a glucopyranosic monomer m-
DOG-linked to an open-chain C-glucosidic monomer. Two examples of this 
kind of dimer are represented by Reginins B (28a) and A (28b), which have the 
4,6-HHDP unit of a pedunculagin (11b) monomer bound to the O-5-galloyl 
group of either stachyurin (13) or casuarinin (14) (Fig. 5). [Xu 1991] The para-
DOG type unit, also referred to as the tergalloyl unit, is less common, probably 
due to its higher steric demand. One example representing this class of 
oligomers is the dimer of tellimagrandin I (5b), named eucalbanin C (29), 
which has been isolated from Eucalyptus alba (Myrtaceae). 
In the GOD-type unit, which seems to be present only in its meta version, a 
HHDP unit of one monomer is C–O-linked to a G unit of another monomer. 
Furthermore, this kind of inter-unit linkage refers to as the sanguisorboyl unit 
and is observed in few oligomers, whose examples can be represented by the 
dimer sanguiin H-6 (30), isolated from Sanguisorba officinalis (Rosaceae). 
[Tanaka 1985] 
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Fig. 10 Typical examples of Okuda’s DOG-type dimeric ellagitannins 
 
As ellagitannins and vegetal extracts rich in ellagitannins show many beneficial 
biological activities toward the cardiovascular system as described in the 
following paragraph, the effects of ENC have been tested for their ability to 
affect some cardiovascular functions and to exert some protective effects. 
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Fig. 11 A typical example of Okuda’s GOD-type dimeric ellagitannin 
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CHAPTER 4 
 
Biological effects of ellagitannins and vegetal 
extracts rich in ellagitannins toward 
cardiovascular system 
 
Cardiovascular system 
 
Ellagitannins are shown to determine many beneficial effects towards the 
cardiovascular system. 
A positive association between walnuts and pomegranates consumption and 
cardiovascular health benefits has been observed. Both contain relevant 
amounts of phenolic antioxidants, and in particular ellagitannins (ETs) that 
have been shoen responsible, at least partly, of these physiological properties. 
[Espín 2007a]  
These phytochemicals possess many biological effects in vitro that have been 
connected to pharmacological (ET-rich medicinal plants) and nutritional (ET-
rich foods) effects in vivo. These activities are mainly related to the field of 
prevention of cardiovascular diseases and cancer. The in vivo biological effects 
are, at least in part, due to the high free-radical scavenging activity observed in 
vitro assays. Many nutraceuticals, medicinal plant extracts and food products 
rich in hydrolysable tannins, and particularly in ETs, are currently marketed 
and proposed for their potential benefits on cardiovascular health.  
Many plant species containing ETs have been used for the treatment of 
diseases, particularly in Asia [Okuda et al. 2009]. Among these plants, 
Agrimonia pilosa (agrimoniin), Camelia japonica (camelliatannin A), Cornus 
officinalis (cornussin A), Geranium thunbergii (geraniin), Geum japonicum 
(gemin-A), Liquidambar formosana (casuarictin), Mallotus japonicus 
(mallotusinic acid); Oenothera erythrosepala (oenothein B), Punica granatum 
(granatin B), Rosa rugosa (rugosin) and Terminalia chebula (chebulinic acid) 
are to be included. All the mentioned medicinal plants are clinical used for 
their antioxidant, anti-diarrheic, anti-microbial and immunomodulatory 
activities. 
  33 
ETs are also present in significant amounts in different berries, such as 
strawberries, red and black raspberries [Zafrilla et al. 2001], blackberries, and 
nuts including walnuts [Fukuda, T et al. 2003], pistachio, cashew nut, 
chestnuts, oak acorns [Cantos et al. 2003] and pecans [Villarreal-Lozoya et al. 
2007]. In addition, they are shown to present in large amounts in pomegranates 
[Gil et al. 2000], and muscadine grapes (Sandhu AK, et al.,  2010)., and are 
important constituents of wood, particularly oak wood. [Glabasnia et al. 2006] 
EA, in addition, has also been found to be present in different types of honey. 
[Ferreres et al. 1996] 
Free EA and several glycosidic derivatives, including glucosides, rhamnosides, 
arabinosides and the corresponding acetyl esters, are present in these food 
products. [Zafrilla et al. 2001] 
As oxidative stress is linked to atherosclerosis which represents the etiological 
base of cardiovascular diseases, [Kaneto et al. 2010] the antioxidant activity of 
fruit and plant extracts rich in EA, GA and (or) hydrolysable tannins has been 
considered, in part, responsible for the beneficial effects of Ets. [Serrano et al. 
2009] [Basu et al. 2009] 
Furthermore other beneficial biological activities of ellagitannins have been 
reported. 
The anti-atherogenic, anti-thrombotic, anti-inflammatory and anti-angiogenic 
effects of fruits and plants extracts rich in EA, GA and (or) hydrolysable 
tannins (ETs and GTs) have been observed in several in vitro studies. 
Pomegranate juice and extracts, which contain large amounts of EA and Ets, 
have been shown to have multiple anti-atherogenic effects. 
Paraoxonases (PONs) are lactonases inhibiting LDL-cholesterol peroxidation. 
The PON1 is located on High Density Lipoproteins and it is responsible for its 
antioxidant activity.  
Pomegranate juice is able to prevent lipoproteins oxidation through the up-
regulation of the expression and activity of PON1 and PON2 in hepatic cells 
[Khateeb et al. 2010] and in macrophages [Shiner et al. 2007a] and inducing 
the association of PON1 to HDL [Fuhrman et al. 2010]. In addition, several 
pomegranate extracts are able to determine a reduction of the levels of 
cholesterol in macrophages through the inhibition of the uptake of native and 
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oxidised LDL (ox-LDL) and the stimulation of high density lipoprotein (HDL) 
efflux [Aviram et al. 2008] and to protecte monocytes and endothelial cells 
from peroxide and ox-LDL damage. [Sestili et al. 2007] 
The endothelium possess anti-atherogenic and anti-thrombotic properties due 
to nitric oxide (NO), synthesized by endothelial nitric oxide synthase (eNOS), 
which regulates the vascular function: it inhibits platelets aggregation, induces 
vasorelaxation and represses the expression of inflammatory proteins and 
adhesion molecules such as the intercellular adhesion molecule (ICAM-1) and 
the vascular adhesion molecule (VCAM-1) both involved in the endothelial 
migration of leukocytes. [Thomas et al. 2003] 
An adjunctive anti-atherogenic action of pomegranate is represented by its 
ability to induce the expression of eNOS in human artery endothelial cells and 
by its ability to inhibit activated platelets aggregation as well as to reduce the 
production of the circulating platelet activating agent thromboxane A2 
(TXA2). [Mattiello et al. 2009] 
The inhibition of LDL oxidation and the decrease of the levels of ICAM-1 and 
VCAM-1 in human endothelial cells has been reported also with other extracts 
rich in ellagitannins. [Papoutsi et al. 2008] 
Other medicinal plants such as Phyllantus amarus L (Euphorbiaceae) rich in 
ETs exert anti-inflammatory effects through the increase of the expression of 
inducible NOS (iNOS) and of different cytokines in macrophages. [Kolodziej, 
et al. 2005] 
Proteins of the matrix metalloproteinase (MMP) family are involved in the 
breakdown of extracellular matrix and remodeling of the vascular wall. 
Induction of MMPs is associated to vascular smooth cells migration and 
atherogenic processes.  
Medicinal plant extracts, such as Phyllantus urinaria, containing large amounts 
of EA, are able to exert anti-angiogenic effects by decreasing the MMP12 
activity in human endothelial cells. [Huang et al. 2009] Furthermore, the 
extracts rich in GA, grape or red wine extracts, have been shown to determine 
some anti-thrombotic effects through the inhibition of platelets aggregation and 
the activation of the platelets and endothelial cells adhesion molecule 
(PECAM-1) [De Lange et al. 2007]. 
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Another important molecule involved in the vascular function is represented by 
the potent growth factor and inducer of angiogenesis, the vascular endothelium 
growth factor (VEGF). Angiogenesis is considered to represent an important 
factor in the atherosclerotic process and VEGF may have both detrimental and 
beneficial effects [Holm et al. 2009]. Red wine polyphenol extracts have been 
shown to be able to reduce the release of VEGF from human aortic smooth 
muscle cells [Oak et al. 2006]: this mechanism may represent a way through 
which these compounds exert beneficial effects against the formation of the 
atherosclerotic plaque. Furthermore, dealcoholized red wine is able to reduce 
hepatic intracellular levels of cholesterol as well as the secretion of 
apolipoprotein B100 (ApoB100) [Pal et al. 2003], a component of the LDL 
particles essential for the binding of LDL particles to the receptor for cellular 
uptake [Chan et al. 2006].  
Other fruit extracts such as mulberry extract rich in GA are able to reduce the 
growth, migration and MMPs activity of rat thoracic smooth muscle cells 
[Chanet al. 2009] whereas the plant extract from Rhus coriaria rich in GTs 
determines endothelium-dependent vasorelaxation in isolated rabbit aortic 
rings [Beretta et al. 2009]. Overall, these results lead to suppose that either a 
component or components present in the tested extracts, presumably EA, GA 
or hydrolysable tannins, exert potential preventive effects towards the 
development of atherosclerotic lesions. 
A total of thirteen studies about the responses of different vascular cell models 
exposed to EA and (or) punicalagin, which are the main pomegranate 
polyphenols [Zhang et al. 2009], suggest that these two compounds may 
contribute to determine the anti-atherogenic effects of pomegranate extracts or 
juice. In addition, EA has been shown to possess anti-inflammatory effects 
through the reduction of the levels of prostaglandin synthases [Karlsson et al. 
2010] and the reduction of the expression levels of adhesion molecules 
including ICAM-1, VCAM-1 and E-selectin [Papoutsi et al. 2008] [Yu et al. 
2007]. Furthermore, EA is able to exert anti-angiogenic effetcs through the 
reduction of the levels of the metalloproteinase MMP12 [Huang et al. 2009] 
and the inhibition of VEGF-induced endothelial and vascular smooth muscle 
cells migration [Labrecque et al. 2005]. EA and punicalagin have also been 
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shown to reduce or delay lipoproteins oxidation [Anderson et al. 2001] and to 
increase the expression of paraoxonases PON1 and PON2 [Fuhrman et al. 
2010] [Khateeb et al. 2010]. These two compounds also modulate the 
metabolism of cholesterol and the uptake of native and ox-LDL in 
macrophages [Aviram et al. 2008]. In addition, punicalagin has been shown to 
induce NO production in bovine aortic endothelial cells [Chen et al. 2008] and 
to reduce IL-2 expression in lymphocytes [Lee et al. 2008]. 
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Fig. 12 A typical example of Okuda’s GOD-type dimeric ellagitannin 
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In addition, different other ETs isolated from several plants used in traditional 
medicine have been shown to exert anti-inflammatory, anti-atherogenic and 
metabolic effects. For example, macrocyclic hydrolysable ETs such as 
oenothein B, corilagin, cuphiin D, geraniin, woodfordin C, casuarinin or 
agrimoniin are able to determine immunomodulatory effects through the 
alteration of the levels of various cytokines and (or) the production of NO. 
[Schepetkin et al. 2009] [Zhao et al. 2008] [Kolodziej et al. 200] [Okabe et al. 
2001] [Chen et al. 2000] (Pan et al. 2000] [Ishii et al. 1999] [Murayama et al. 
1992] 
Corilagin is able to reduce TNF-α levels, different interleukins such as and 
iNOS, whereas it enhances iNOS and cytokines in macrophages. Furthermore, 
other anti-atherogenic properties of corilagin include the inhibition of 
monocytes adhesion to endothelial cells and the proliferation of vascular 
muscle cells.  
In addition, some ETs may affect lipid metabolism, thus, atherosclerosis 
development. For example, EA and some ETs present in the Chinese plant 
Geum japonicum (gemin-A (Fig 13)and -B, casuarinin, pedunculagin, etc.) 
have been shown to reduce the activity of fatty acid synthase (FASN) [Liu et 
al. 2009], an important lipogenic enzyme involved in the catalyze of the 
synthesis of long-chain saturated fatty acids [Menendez et al. 2009].  
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ETs such as lagerstroemin, flosin B, stachyurin, etc. present in large amounts in 
Lagerstroemia speciosa (L.) Pers., used in Folk Medicine as anti-diabetic and 
weight loss herb, are able to modulate insulin-like glucose uptake in adipocytes 
and to inhibit adipocyte differentiation [Hattori et al. 2003]. 
In addition, GA, GTs and some derived gallic esters have been tested for their 
potential anti-inflammatory and anti-atherosclerotic effects,  through in vitro 
vascular cell models.  
Several studies have repeatedly shown that GA exhibits none or very weak 
activity on some of the tested models. For example, GA does not affect the 
stimulated release of VEGF from vascular smooth muscle cells [Oak et al. 
2006] and does not alter the levels of eNOS expression [Wallerath et al. 2005] 
and NO production [Huisman et al. 2004] in endothelial cells. Although, GA is 
able to modulate the vasorelaxation properties of the endothelium of isolated 
rat aorta [Sanae et al. 2002] [Sanae et al. 2003] it does not relax the pre-
contracted rat aortic rings (Andriambeloson, E. et al., 1998) As regards 
platelets functionality, GA has no effect towards ADP-induced platelets 
aggregation or PECAM-1 activation (de Lange, D.W. et al., 2007) however, it 
inhibits P-selectin-mediated adhesion between platelets and monocytes 
(Appeldoorn, C.C.M. et al., 2005) and it prevents the inhibitory effects of other 
polyphenols on induced platelets aggregation (Crescente, M. et al., 2009). It 
has been observed, in hepatic cells, that GA is able to slightly reduce the 
secretion of ApoB (Pal, S. et al., 2003) and, in macrophagesm to determine a 
small but significant induction of the tumor necrosis factor TNF-α. (Wang, J. et 
al., 2002a) In contrast, penta-O-galloyl-b-D-glucose, a gallotannin, seems to 
have better anti-inflammatory and anti-atherogenic activities than GA. The 
pentagalloyl glucose does not reduce iNOS expression and activity as well as 
NO production (Kim, M.-S. et al., 2009) (Chen, Y.-C. et al., 2000) (Pan, M.-H. 
et al., 2000). Important pentagalloyl glucose biological activities include the 
suppression of the expression of pro-inflammatory cytokines such as 
interleukins and TNF-a (Lee, S.H. et al., 2007) (Oh, G.S. et al., 2004), the 
inhibition of platelets aggregation (Jeon, W.K. et al., 2006), the  relaxation of 
pre-contracted aortic rings and the reduction of the expression of VCAM-1, 
ICAM-1 or the monocyte chemoattractant protein-1 (MCP-1) in human 
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endothelial cells (Kang, D.G. et al., 2005). In addition, the pentagalloyl glucose 
is able to promote glucose transport in adipocytes and to inhibit adipocytes 
differentiation exerting potential beneficial effects in diabetes and metabolic 
syndrome. (Klein, G. et al., 2007) (Ren, Y. et al., 2006)  
Many in vitro cell studies indicate that EA, GA and hydrolysable tannins 
possess potential antiatherogenic properties.  
Some of these ETs physiological derivatives have now been identified: EA and 
its colonic metabolites, UroA and UroB, as well as their derived glucuronides, 
sulphates and methylated compounds are the molecules most likely to reach 
and enter the endothelium and vascular system. In addition, most published 
reports indicate that the circulating concentration of EA and urolithins 
metabolic derivatives is in the nM to low lM range (Cerdá, B. et al., 2004) 
(Cerdá, B. et al., 2005a) (Espín, J.C. et al., 2007b). In relation to GA absorption 
and metabolism, both GA and its primary metabolite, 4-methyl GA (4-
OMeGA), have been identified in the urine and plasma of human volunteers 
with plasma concentrations in the low lM range (Loke, W.M. et al., 2009) 
(Mennen, L.I. et al., 2008). In rats, the plasma levels of GA and 4-OMeGA 
reached a Cmax of approximately 1.8 and 
0.4 lM, respectively, after the consumption of grape seed extract (Ferruzzi, 
M.G. et al., 2009). Few information is disposable for the metabolic fate and 
bioavailability of other macrocyclic hydrolysable tannins which, probably, are 
not absorbed intact and do not reach the systemic blood stream and the 
vascular cells in its original form. 
As regards the activity of the metabolites, few reports on the anti-inflammatory 
effects of some methyl EA derivatives and of 4-OMeGA have been published. 
In particular, 4-OMeGA has been demonstrated to reduce the expression of 
iNOS, IL-1b and TNF-a in macrophages (Na, H-J. et al., 2006) as well as the 
expression of adhesion molecules ICAM-1 and VCAM-1 or the production of 
VEGF in endothelial cells (Lee, G. et al., 2006) (Jeon, K.S. et al., 2005). 
However, these studies were carried out using very high concentrations of the 
metabolite (from 2.5 to 100 lM). In vivo studies about the cardiovascular 
effects of hydrolysable tannins have also been conducted. 
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Ellagic acid has been shown to augment the partially activated thromboplastin 
time and to decrease the platelets number, fibrinogen, kininogen and 
prekallilrein plasma levels in addition to inducing a hypotensive effect.  
(Majid, S. et al., 1991), reported that the administration of EA in drinking 
water to mice for 8 weeks, determines an antioxidant effect with augmented 
activity of GSH and GR in liver and lungs and reduced levels of MDA. In 
another experiment carried out in rabbits, 1% EA, given together with 
atherogenic diet for eight weeks, has been shown to determine a reduction of 
atherosclerotic lesion, oxidative DNA damage and apoptosis in the aorta (Yu, 
Y.M. et al., 2005). In addition, the administration of coencapsulated EA in 
nanoparticles with coenzyme Q10 to rats fed with a high-fat diet has been 
observed to determine an improvement in the endothelial function and a 
reduction of total cholesterol and triglycerides in plasma(Ratnam, D.V. et al. 
2009) 
Many studies regarding EA have been carried out with ETs or EA-containing 
foodstuff. In general, these studies have been exerted using pomegranate or 
derived products such as pomegranate extracts or juice. These studies lead to 
suppose that the potential cardioprotective effect of ETs and/or EA is not 
linked to a single effect but EA seems to affect several parameters involved in 
cardiovascular health. The principle effect observed is the reduction of 
oxidative stress in plasma and tissues, including the aortic tissue. Several 
studies indicate that EA induces a reduction in plasma and macrophage lipid 
peroxidation levels (Aviram, M. et al., 2000) (Aviram, M. et al., 2008) 
(Kaplan, M. et al., 2001) (Rosenblat, M. et al., 2006b), and an effect on nitric 
oxide metabolism augmenting the activity and the  expression of eNOS and 
levels of NO (de Nigris et al., 2005, 2007a,b). In addition, the antioxidant 
activity reducing the oxidative stress associated with atherosclerosis  is 
coherent with the observed decreased levels of 8-oxo-dG in aorta and urine (Yu 
et al., 2005; Fukuda et al., 2004), decreased plasma isoprostane levels and 
modulation of redox sensitive transcription factors like ELK-1, p-JUN and p-
CREB (de Nigris, F. et al., 2005) (De Nigris, F. et al., 2007b). Another 
parameter modulated by ETs is the effect on the lipid profile. The intake of 
diverse pomegranate-derived extracts or juice seems to modify the blood lipids 
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profile regardless of the animal model used (hypercholesterolemic diet, 
streptozotocin treated, Zucker diabetic fat rats, ApoE deficient mice).  
A general reduction of triglycerides, total cholesterol, LDL, VLDL, and non 
esterified free fatty acids plasma levels has been reported (Li, Y. et al., 2005a) 
(Lei, F. et al., 2007) (Aviram, M. et al 2008) (Bagri, P. et al., 2009) (Ratnam, 
D.V. et al., 2009) (Huang, T.H. et al., 2005a) as well as a modulation of genes 
involved in lipid metabolism such as PPAR-a, FATP, CPT-1, ACO and 
AMPKa2 (Huang, T.H. et al., 2005a) (Shimoda, H. et al., 2009). In addition, 
EA and ETs consumption seems to affect parameters related to lipoproteins 
such as their susceptibility to oxidation. In this line, studies carried out in ApoE 
deficient mice have shown a reduction of the LDL oxidation and a decreased 
ox-LDL uptake by macrophages (Aviram, M. et al., 2000) (Aviram, M. et al., 
2008) (Kaplan, M. et al., 2001) (Rosenblat, M. et al., 2006b). Furthermore, the 
effect of different products derived from pomegranate on the increased activity 
and expression of paraoxonase enzymes (PON1 and PON2) that are increased 
in plasma and macrophages, respectively, following consumption of 
pomegranate products have been reported (Kaplan, M. et al., 2001) (Aviram, 
M. et al., 2008) 
In addition, EA and pomegranate exert hypotensive and anti-diabetic effects. 
An extract of Terminalia arjuna, administered i.v. to rats, determines a 
reduction of blood pressure and heart rate (Takahashi, S. et al. 1997). 
The administration of 100–300 mg/kg/day for 4 weeks of pomegranate juice 
extract to diabetic rats treated with angiotensin II decreased mean arterial blood 
pressure and the biochemical changes induced by diabetes and angiotensin II 
(Mohan, M. et al., 2009). The administration of pomegranate flower extract 
augments oral glucose tolerance and reduces the fasting glucose plasma levels 
(Huang, T.H. et al., 2005a) (Bagri, P. et al., 2009) (Hontecillas, R. et al, 2009) 
showing some anti-diabetic effects for these compounds. The probable 
mechanisms determining these anti-diabetic effects involve an augment of 
PPAR-c expression in cardiac, skeletal muscle and adipose tissue (Huang, T.H. 
et al., 2005b) (Hontecillas, R. et al, 2009) Some mentioned studies have been 
exerted using pomegranate-derived extracts that not only contain polyphenols 
but also fibre, sugars, organic acids and other compounds that may contribute 
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to the observed effects. However, even if some compounds not belonging to 
the class of hydrolysable tannins such as the triterpenoid 3b-hydroxy-olea-12-
en-28-oic acid have been reported to posses beneficial effects towards the 
cardiovascular system, these compounds show a very low biodisponibility. 
(Huang, T.H. et al., 2005a) Clinical data about ET-containing foodstuffs 
consumption and cardiovascular diseases have been reported. Most of these 
foodstuffs include pomegranate and walnuts. 
Both pomegranates and walnuts (Banel, D.K. et al., 2009) have been observed 
to exert some cardioprotective effects. Despite both contain large amounts of 
ETs, in the case of pomegranate the beneficial effects are believed to be due to 
the fraction of ETs with antioxidant effects, whereas as regards the beneficial 
effects of walnuts, these are considered to be induced mostly by their lipid 
fraction (Ros, E. et al., 2006). However, other constituents such as different 
polyphenols, phytosterols, tocopherols, L-arginine and magnesium could 
contribute to the cardioprotective effects of walnuts (Casas-Agustench, P. et 
al., 2010) (López-Uriarte, P. et al., 2010) 
Aviram and Dornfeld (2001) reported the cardiovascular benefits of 
pomegranate juice in a no placebo-controlled and no crossover study which has 
been carried out in only 13 healthy volunteers. In this study the augment of 
(20%) of serum PON1 (an HDL-associated esterase that can protect against 
lipid peroxidation) together with the ex-vivo reduction susceptibility of LDL 
oxidation have been observed. No changes in serum lipid profile have 
occurred. Even if the authors assessed that the active compounds are the 
‘antioxidant flavonoids’ of the juice, this is probably untrue because flavonoids 
represent the minor constituents in pomegranates compared to the non-
flavonoid polyphenols ETs, so perhaps, authors mixed up the terms flavonoid 
and polyphenol. 
In addition to the mentioned study, fifteen further human intervention studies 
with pomegranate have been carried out. Most studies have been done in order 
to justify the cardiovascular health benefits observed on the base of the 
impressive in vitro antioxidant activity of pomegranate (Gil, M.I. et al., 2000). 
Howeverthe EA and ET fraction, once ingested, undergoes a extensive 
metabolism by the gut microbiota to produce principally urolithins A and B 
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with negligible antioxidant activity (Cerdá, B. et al., 2004). The activity of 
punicalagin, incubated in vitro with macrophages, has been tested in order to 
explain the in vivo effects such as the increase of PON2 (Shiner, M. et al., 
2007a). However, considering the fact that punicalagin concentration used in 
the mentioned study will never be reached in the bloodstream, other 
mechanisms should have to be involved. 
Furthermore, several studies about pomegranate and cardiovascular system 
(many of them with the same co-authors), in addition to the improvement of 
serum lipid profile and serum antioxidant activity, reported other beneficial 
effects including the reduction of systolic blood pressure (Aviram et al., 2001, 
2004) and decrease of carotida intima-thickness (Aviram et al., 2004) 
(Davidson, M.H. et al., 2009). 
Other additional mechanisms which may contribute to the cardiovascular 
protection of pomegranate juice have been related to its potential estrogenic-
related effects (Sturgeon, S.R. et al., 2010). These effects occur through the 
inhibition of cyclooxygenase, 17b-hydroxysteroid dehydrogenase and 
aromatase activities observed in vitro and in animal models due to the tentative 
action of constituents such as punicic acid, EA, and anthocyanins.  
Larrosa and colleagues (2006b) (Larrosa, M. et al., 2006b) showed dose-
dependent estrogenic and anti-estrogenic activities of urolithin A and B in 
vitro, using molecular and cellular models.  
In the study of Seeram and colleagues (Seeram, N.P. et al., 2006a) involving in 
postmenopausal women (n = 11), a significant increase in serum estrone levels 
has been observed, however, but this had no any significant estrogenic-related 
effects. 
The beneficial effects of walnuts consumption on cardiovascular disease have 
been widely reported.  
A recent review of 25 intervention trials reported that nut consumption 
improves blood lipid levels in a dose-dependent manner. (Sabaté, J. et al., 
2010) 
Interestingly, different types of nuts (such as almonds, which do not contain 
ETs) show a similar activity profile regarding the influence on blood lipid 
  44 
levels which could limit the possible specific role of ETs in the mediation of 
these effects.  
As regards this field, walnuts or canola oil consumption, showing similar fatty 
acid composition, have been shown to exert similar LDL-cholesterol lowering 
effects (Chisholm,  et al.  2005). 
However, recent reports claim for cardiovascular benefits beyond blood lipid 
lowering (Ros, E., 2009). In addition, walnuts consumption has been associated 
to an increase of plasma total antioxidant capacity (FRAP and ORAC assays) 
and the decrease of plasma lipid peroxidation (TBARs and MDA)  and these 
effects are believed to be due to plasma phenolic content. (Torabian, S. et al. 
2009) 
Different studies  to assess the properties of walnuts to impart ‘functional 
properties’ in meat products, i.e. improvement of antioxidant (Canales, A. et 
al., 2007) or thrombogenic (Canales, A. et al., 2009) status have been 
conducted and a possible contribution of ETs-derived metabolites in the 
determination of these effects can not be excluded, even if a combined 
synergistic effect of different walnut constituents has been supposed for the 
beneficial effects. 
In general, the number of human intervention studies dealing with 
cardiovascular protection and ET-containing foodstuffs is small.  
A recent study about the effect of pomegranate juice on patients with a 
moderate risk for cardiovascular disease involved 289 participants with a 
follow-up for 18 months. (Davidson, M.H. et al., 2009) 
As regards walnuts, more intervention studies are disposable. Sabaté and 
colleagues (2010) have recently reviewed 25 nut consumption trials among 583 
participants, which make an average sample size of 22 participants per trial. In 
different studies, referring to blackberries, strawberries, muscadine grape and 
E. officinalis extract, the sample size ranged from 6 to 30 people. 
The lack of crossover studies represents the weak point about the human 
intervention studies carried out with pomegranate. In fact, only one crossover 
study with pomegranate ETs with the principle aim to evaluate the effect of ET 
consumption on strength recovery after eccentric exercise has been carried out 
(Trombold, J.R. et al., 2010).  
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The scientific evidence supporting cardioprotective effects upon walnuts 
consumption is stronger than that related to pomegranate consumption taking 
into account the number of intervention studies, sample size and number of 
crossover studies which confer relevant statistical power to the results. 
Bioavailability and metabolism issues represent critical points to identify the 
probable compounds involved in the cardiovascular-related effects observed. In 
the pomegranate studies, the tentative bioactive compounds are ETs. 
According to previous reports, the main detected metabolite in bloodstream (at 
micromolar level) is urolithin A glucuronide (Cerdá et al., 2004) (Seeram 
et al., 2006b) (Espín, J.C. et al., 2007b) (Tomas-Barberan, F.A. et al., 2009) 
leading to suppose that this compound must be somehow involved in the 
effects observed, and this action is not necessarily related to a traditional free-
radical scavenging ability but probably to its interference with the signalling 
cascades such as those involved in atherothrombosis (monocyte adhesion to 
endothelium, cytokine production, regulation of transcription factors, etc. 
(González-Sarrías, A. et al., 2009) (González-Sarrías, A. et al., 2010b) (Larrosa 
et al., 2010). If urolithins (in particular UroA glucuronide) are involved in the 
cardioprotective effects of ET-containing foodstuffs, the role of gut microbiota 
in the biological effects of ET-containing foodstuffs has to be considered, as 
the ability of each individual to produce the gut microbiota-derived metabolites 
urolithins would be critically related to the biological effects. In other words, 
the activity deriving from the intake of pomegranate or walnuts could could be 
different depending on the gut microbiota. In fact, people can be divided into 
high, low and very low urolithin-producers (Cerdá et al., 2005, 2006) 
(González-Sarrías, A., et al., 2010a).  
This could be a reason explaining the diverse results obtained in some studies 
carried out with both pomegranates and walnuts. Therefore, human 
intervention studies with ETs should include a sample size of population 
enough (n > 60) to obtain statistically significant results depending on the 
capacity of the individuals to produce urolithins.  
Oxidative stress has been reported to exert a relevant role in many 
cardiovascular diseases, such as atherosclerosis, hypertension, myocardial 
infarction, etc. (Levonen, A.L., et al., 2008). For this reason, the ‘antioxidant 
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activity’ (measured with many different techniques and models) of a compound 
has been often related to the potential cardioprotective effects of such 
compound. 
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CHAPTER 5 
 
Cardiovascular effects of ENC 
 
5.1 Heart 
Since ellagitannins and vegetal extracts rich in ellagitannins have many 
beneficial effects toward the cardiovascular system, the effects of ENC toward 
the cardiovascular system of ENC have been tested. 
Sweet chestnut bark extract was tested for its cardiovascular profile in guinea 
pig left atrium and left papillary muscle driven at 1 Hz and in spontaneously 
beating right atrium to evaluate its negative inotropic and/or chronotropic 
effects, respectively. The data, relative to about to 10 minutes of incubation 
with the extract, are reported in Table 1. It should be noted that the extract (1 
mg/ml) produced a positive inotropic effect (+ 218 ± 17 %) in left atrium even 
though with a concomitant reduction in heart rate (– 59 ± 3.6 %) A single dose 
(1 mg/ml) of ENC reduces the heart rate in right atrium and simultaneously 
increases the contraction on left atrium. Chestnut extract (1 mg/ml) revealed a 
positive inotropic effect are on also seen on the left papillary muscle stimulated 
at 1 Hz where we evaluate effect on the ventricular contraction (inotropy). All 
the reported effects are reversible after 30 minutes of washing. 
 
Table 1. Activity of Sweet Chestnut bark extract in Guinea pig heart preparations. 
 
Comp Tissue 
 Left Atrium Right Atrium Papillary Muscle 
 Positive Inotropic 
Activitya 
Negative 
Chronotropic 
Activityb 
Positive Inotropic 
Activityc 
Ext  1mg/ml 218 ± 17 59 ± 3.6 42 ± 2.1 
 
a Increase in developed tension on isolated guinea-pig left atrium, expressed as percent changes from of 
the controls (n = 5-6). The left atria were driven at 1 Hz. b Decrease in atrial rate on in guinea-pig 
spontaneously beating isolated right atrium, expressed as percent changes from the control (n = 7-8). 
Pretreatement heart rate ranged from 165 to 190 beats/min. c Increase in developed tension on isolated 
guinea-pig left papillary muscle, expressed as percent changes from the control (n = 5-6). The left 
papillary muscle were driven at 1 Hz. Data represent mean ± S.E.M.. All data refer to 10 minutes of 
incubation. 
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Fig 14: Time course of extract (1 mg/mL) on positive inotropic effect in guinea pig left atria driven at 1 
Hz (magenta) and on negative chronotropic effect in spontaneously beating right atria (green), 
respectively. Values are means ± SEM (n = 5–6). Where error bars are not shown these are covered by the 
point itself. 
 
To evaluate the time course of simultaneous positive inotropic and negative 
chronotropic negative effects on left and right atria respectively, we measured 
the effect of single dose (1 mg/mL) every 5 minutes to for 30 minutes. The data 
are collected in table 3 and shown in Figure 14. 
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Fig. 15. Potency of extract on positive inotropic effect in guinea pig left papillary muscle driven at 1 Hz 
(magenta). Values are means ± SEM (n = 4–7). Where error bars are not shown these are covered by the 
point itself. 
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The intrinsic positive inotropic activity is reduced by about 50 % after 30 
minutes. In fact, calculating the inotropic and chronotropic potency by 
cumulative curve after 30 minutes of incubation for each concentration, the 
intrinsic activity does not exceed 50% with the exception of positive inotropy 
on papillary muscle (Figure 15). Data are collected in Table 3. 
 
Table 2. Cardiac Activity and potency of ENC 
 
 Positive Inotropy Negative 
Chronotropy 
 Left Atria Left Papillary Muscle Right Atria 
 Activitya Potencyb Activitya Potencyb Activitya Potencyb 
Ext 45 ± 0.7   52 ± 1.9 0.09 0.07-0.13 48 ± 2.3   
 
a Increase in developed tension on isolated guinea-pig left atrium at 1 mg/ml, expressed as percent changes from the 
control (n = 5-6). Data represent mean ± S.E.M.. The left atria were driven at 1 Hz. 1 mg/ml gave the maximum effect 
for extract. b The 50% of effect concentration (EC50) was expressed as mg/mL concentration and was calculated from 
concentration-response curves (Probit analysis by Litchfield and Wilcoxon [Tallarida 1987] with n = 6-7). c Increase in 
developed tension on isolated guinea-pig left papillary muscle at 1 mg/ml, expressed as percent changes from the 
control (n = 5-6) The left papillary muscle were driven at 1 Hz. 1 mg/ml gave the maximum effect for extract. Data 
represent mean ± S.E.M.. d Decrease in atrial rate on guinea-pig spontaneously beating isolated right atrium at 1 
mg/mL, expressed as percent changes from the control (n = 7-8). Data represent mean ± S.E.M.. Pretreatement heart 
rate ranged from 165 to 190 beats/min. 1 mg/ml gave the maximum effect for extract. 
 
These very interesting results led us to exclude some mechanisms responsible 
for the effects seen for extract. 
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Fig 16. Cumulative concentration-response curves for extract in absence ( ) and in presence of 
atropine(1 μM) ( ) in guinea-pig spontaneously beating right atria. Each point is the mean ± SEM of 
four-six experiments. Where error bars are not shown these are covered by the point itself. 
 
To clarify the mechanisms involved in the observed negative chronotropic 
effect and in order to elucidate the implication of cholinergic system, the 
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spontaneous right atrium was treated with extract in presence and in absence of 
1 µM atropine to test an implication of cholinergic system in chronotropic 
effect.  
The figure 16 shows the cumulative negative chronotropic effect of chestnut 
extract in presence of atropine. As shown in Figure 16 the presence of atropine 
does not modify the effect of the extract on heart rate. The right atrium 
preparations were exposed simultaneously to extract (1 mg/ml) with atropine (1 
µM) (Figure 17). As shown in Table 3, the pA2 of atropine does not change in 
the presence of the extract. The extract does not change even the pA2 inotropic 
effect on spontaneous activity of the right atrium: perhaps indicating that the 
negative chronotropic effect is not mediated by cholinergic receptor 
modulation.  
 
Table 3. Antagonist affinities at guinea pig right atria, expressed as pA2 Values 
Comp  Right Atriuma 
  Inotropy Chronotropy 
Atropine pA2b 9.45 ± 0.04 9.21 ± 0.03 
Atropine + ENC pA2b 9.41 ± 0.03 9.19 ± 0.02 
a The agonist was carbachol. b Each pA2 values was obtained for three different concentrations and were 
calculated from Schild plots, [Arunlakshana 1959] constrained to slope –1.0 [Tallarida 1987]. Results are 
presented as mean ± S.E..  
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Fig. 17. Effect of extract on carbachol-induced negative chronotropic activity of isolated guinea pig 
spontaneously beating right atrium. Cumulative dose-response curves were obtained before and after 
simultaneously exposure to extract (1 mg/mL) and atropine (1 µM) for 30 min. Each point is the mean ± 
SEM (n = 5–6). Where error bars are not shown these are covered by the point itself. 
 
For the positive inotropic effect, showed by the extract on guinea pig left 
atrium driven at 1 Hz, has been verified the involvement of the adrenergic 
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receptor. The positive inotropic effects of chestnut extract (1 mg/ml) in left 
atrium, also persist in the presence of propranolol (1 µM), (Figure 18).  
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Fig. 18. Cumulative concentration-response curves for extract in absence ( ) and in presence of 
propranolol (1 μM) ( ) in guinea-pig left atria driven at 1 Hz. Each point is the mean ± SEM of four-
six experiments. Where error bars are not shown these are covered by the point itself. 
 
5.2 Guinea pig aortic strips 
Chestnut extract was tested on K+ (80 mM) or Na (1µM) depolarizing guinea 
pig aortic strips to assess their vasorelaxant activity. Chestnut extract (1 mg/ml) 
spasmolytic activity was less than 50% against potassium chloride and 
norepinephrine. The figure 6 shows the effects of extract against the 
contraction induced by KCl and NA. As shown in figure 19, the effects are 
almost completely reversible. 
 
 
Fig 19. Spasmolytic activity of extract against contraction induced by NA (1 µM) and potassium chloride 
(80 mM). a) The effect was expressed in milligrams of contraction. b) The effect was expressed in 
percentage of the control. (black) effect of agonist. (green) effect of agonist in presence of chestnut 
  52 
extract (1 mg/ml). (blu) effect of agonist after washout of extract. Each point is the mean ± SEM of five-
six experiments. Where error bars are not shown these are covered by the point itself. 
For extract was also evaluated the antispasmodic activity against KCl. The 
curve of contraction to KCl in the presence of extract (1 mg/ml) is non 
significantly different from the control. 
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Figure 20. Effect of ENC on potassium chloride-induced contraction in isolated guinea pig aortic strips. 
Cumulative dose-response curves were obtained before and after exposure to ENC (1 mg/ml) for 30 min. 
Each point is the mean ± SEM (n = 5-6). Where error bars are not shown these are covered by the point 
itself. 
 
During incubation with ENC (1 mg/ml) for 30 minutes we observed a 
interesting contraction that stabilizes within 30 minutes that we have calculated 
the potency [EC50 = 0.18 mg/ml (c.l. 0.14–0.19)]. The maximum effect is 
reached at 1 mg/ml. This contraction is inhibited by 44.7 ± 3.8 % by 
nicardipine (1 µM). 
 
5.3 Antioxidant and cytoprotective effects of Sweet 
Chestnut bark extract in cultured rat cardiomyocytes 
 
Sweet Chestnut bark extract is particularly rich in tannins (77% p/p), therefore 
we have investigated the ability of the extract to protect cultured 
cardiomyocytes from oxidative stress. 
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Fig. 21 Cell Viability of cultured cardiomyocytes treated with chestnut extract. Rat cardiomyocytes were 
treated with chestnut extract, solubilized in DMSO, as described in Materials and methods, data are 
reported as means ± S.D.. (A) Cell viability was analysed by the MTT test as reported in Materials and 
Methods, (B) Cell viability was analysed by flow cytometry. Cells were double labelled with Annexin V-
PE 7 AAD, and analyzed by a Guava EasyCyte flow cytometer. Statistical analysis was performed by 
one-way analysis of variance (ANOVA) followed by Dunnett’s test., *p < 0.05 with respects to controls. 
 
Figure 21 shows, by MTT (A) and flow cytometry analysis (B), that chestnut 
extract did not exert any toxic effect on cultured primary cardiomyocytes on a 
wide range of concentrations, (1-100 µg/ml). A significant decrease in ROS 
production, as detected by DCFH-DA assay, was observed in chestnut extract-
treated cardiomyocytes following exposure to H2O2. The ability of the extract 
to reduce ROS production was already detected at 1µg/ml concentration. 
Vehicle controls containing equivalent volumes of DMSO (0.2% v/v) did not 
show any significant difference in comparison to cells exposed to H2O2. ROS 
levels were significantly reduced in extract-treated cells after 24 h in a dose 
dependent fashion. Incubation of cardiomyocytes with 100 μM H2O2 for 30 
min caused a significant decrease in cell viability (Figure 21), as detected by 
MTT reduction assay. Treatment of cardiac cells with chestnut extract at the 
concentration of 50-100 µg/ml for 24h prior to H2O2 exposure partially 
protected against oxidative damage, as shown by the significant increase in cell 
viability with respect to H2O2-treated cells. 
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Fig. 22 Effect of Sweet Chestnut bark extract treatment on cell viability in cardiomyocytes exposed to 
H2O2. Cardiomyocytes were treated with chestnut extract (1-100 μg/ml) for 24h before the addition of 
100 μM H2O2, and cellular damage was assessed by the MTT assay and reported as percent cell viability 
in comparison to control cells. Each bar represents the mean ± S.D.. of four independent experiments. 
Data were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett’s test, *p < 0.05 
with respect toH2O2-treated cells, °p<0.05 with respect to control cells. 
 
5.4 Discussion 
Many studies have described the relation between cardiac dysfunction and 
potential initiating factors such as smoking, excessive alcohol consumption, 
diet, obesity, stress and so on. In several cases, the effect of one this factors 
alone or in combination with other initiating factors, as atherosclerosis and 
hypertension, represents a first step in the development of myocardial ischemia 
that plays a central role in the onset and development of different cardiac 
dysfunctions such as angina, infarction, arrhythmias or heart failure. [Soufi M, 
et al., 2006] [Woo KS, et al., 1999] 
Different approaches are commonly applied to reduce cardiovascular risks. 
Beside the early identification of risk factors, lifestyles and nutrition habits 
play a fundamental role in preventing or counteracting cardiovascular diseases. 
Epidemiological studies have indicated the existence of an inverse correlation 
between the intake of fruits and vegetables, rich in antioxidant phytochemicals, 
and the risk of developing cardiovascular diseases [Genkinger JM, et al., 2004] 
[Kris-Etherton PM, et al., 2002]. Many phytochemicals have been shown to 
exert antioxidant effect and to counteract many oxidative stress related 
diseases, like cardiovascular diseases [Mizrahi A, et al., 2009]  
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The high potential of Castanea Sativa Mill. was firstly discovered by the 
Romans not only for fruits but also for leaves, flowers and bark. The bark and 
wood of chestnut trees are the prime sources of tannins; different Castanea 
tissues are rich in both simple phenolics and more complex tannins but the 
chestnut wood contains much higher levels of phenolics than the chestnut fruits 
[De Vasconcelos MCBM, et al., 2010]. The extract used in this study has been 
demonstrated to contain more than 10% (w/w) of phenolic compounds, of 
which tannins as Vescalgin and Castalgin are the more representative. It has 
previously been demonstrated that many ellagitannins, including castalagin and 
vescalagin, have potent antitumor, antioxidant, antimicrobial and antimalarial 
properties  [Cerdà B, et al., 2004] [Seeram NP, et al., 2005] [Reddy NM, et al., 
2007].  
Tannins, including proanthocyanidins, exert many biological effects [Haslam 
E., 1996]. Tannins exert a double action towards the cardiovascular system: a 
direct action on heart and blood vessels by modulation of cardiovascular 
parameters and a indirect action through their antioxidant activity. In fact they 
are able to inhibit lipid peroxidation and lipoxygenases in vitro, and to 
scavenge radicals such as hydroxyl, superoxide, and peroxyl [Gyamfi MA, et 
al., 2002]. While antioxidant effects of condensed tannins have been reported 
by several studies, [Guo Q, et al., 1999] there is little information on the 
antioxidant activity of water soluble tannins [Ito H., 2011] [Yoshida T, et al., 
2010]. Hydrolysable tannins, for their high degree of hydroxylated aromatic 
functions, show high antioxidant activity [Koleckar V, et al., 2008]. 
In many countries Pycnogenol® a preparation based on Pinus maritima bark 
extract, a pine from the south of France, is used as a cardioprotective food 
supplement [Packer L, et al., 1999]. The main bioactive compounds of this 
product are oligomeric prontocyanidines and phenolic monomers. 
No data about the cardioprotective effects of chestnut bark extract are reported 
in the literature, therefore in order to validate this hypothesis we have 
characterized the extract, and measured its antioxidant and cytoprotective 
activities in cultured rat cardiomyocytes. Moreover we have investigated its 
inotropic and chronotropic effects in guinea pig cardiac preparations and its 
activity in guinea pig aorta strips. 
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Extract induced transient negative chronotropic effect in isolated spontaneously 
beating right atria and simultaneously positive inotropic effect in left atria 
driven at 1 Hz. On papillary muscle the positive inotropic effect is persistent. 
This effect is particularly interesting, in fact it is known  that a persistent 
positive inotropic effect is useful for ventricular support of heart function and 
for preventing stagnation of blood into the ventricles. 
Surprisingly cardiac cholinergic receptors are not involved in the negative 
chronotropic effect, in fact the preincubation with atropine does not affect the 
negative inotropic effect. Since previous studies have shown that natural 
extract of chestnut is able to bind gut cholinergic receptors in a non-
competitive reversible manner [Budriesi R, et al., 2010], it is possible to 
hypothesize that the extract is able to discriminate between the major 
cholinergic receptor subtypes. In particular, in heart tissue, the bradicardic 
seems not to be mediated by direct interaction with this system. 
The positive inotropic effects are not related to adrenergic receptors because 
the effect of the extract persists even in the presence of propranolol. These 
results demonstrate that both chronotropic and inotropic effect of the extract 
are not due to the main receptor mechanisms involved in heart function 
regulation. 
As regards the vascular smooth muscle, natural extract of chestnut did not 
significantly change the contraction induced by potassium (80 mM) or that 
induced by noradrenaline (1µM). In a previous paper [Budriesi R, et al., 2010] 
we demonstrated that bark chestnut extract exerts antispasmodic activity 
towards the contraction induced by potassium chloride in different gut 
segments. It is well known that the ileum contraction induced by potassium 
chloride involves the activation of L-type calcium channels. [Bolton TB. 1979] 
It is not surprising that the extract does not produce any effects on large 
vessels, as there are many drugs such as calcium channel entry blockers that 
acts selectively in potassium induced ileum contraction without having effects 
on aortic strips. [Budriesi R, et al, 2009] 
Extract did not exhibit antispasmodic effect on the potassium induced 
contraction although, during the incubation period, it showed a weak intrinsic 
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contractile activity. This weak contraction induced by extract is inhibited by 
nicardipine. 
These preliminary findings do not allow us to make statements about the 
mechanism by which the extract induces its direct cardiovascular effects. 
certainly the homeostasis of calcium is involved in its cardiovascular protective 
effects. 
Extracts from Castanea Sativa leaves have been shown to exert an antioxidant 
effect in different “in vitro” model systems and to be useful in the prevention 
of photoaging and oxidative stress mediated skin diseases [Almeida IF, et al., 
2008] [Calliste CA, et al., 2005]. 
Recently, Frantic et al. [Frankič T, et al., 2011] have investigated the effect of 
sweet chestnut wood extract in pigs treated with high doses of n-3 PUFAs to 
induce oxidative stress; the authors demonstrated that the extract treated pigs 
showed a decreased level of many biomarkers of oxidative stress as urine 
MDA and isoprostanes, and lymphocytes DNA damage, suggesting the use of 
chesnut wood extract in animal nutrition to prevent oxidative stress. 
Even though previous studies have demonstrated the ability of chesnut 
(Castanea crenata) inner shell extract to protect HepG2 cells from t-BHP 
induced oxidative stress [Noh JR, et al., 2010], to our knowledge no data are 
available to elucidate the effects of castanea sativa bark extracts on cardiac 
cells. 
In this study the extract did not shows any toxic effect in cultured 
cadiomyocytes in a wide range of concentrations (1 to 100 μg/ml) and resulted 
in a significant protection against H2O2 -induced cytotoxicity and in a marked 
decrease in intracellular ROS production. 
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CHAPTER 6 
 
Diarrhoea, a world-wide health trouble 
 
Gastro-intestinal water-borne infections represent among the most emerging 
and re-emerging infectious diseases throughout the world. These infections 
heat mainly the stomach and the gastro-intestinal tract. They are mostly 
endemic with a worldwide distribution and they have a heterogeneous 
aetiology. Most water-borne diseases that are caused by organism ranging from 
microscopic viruses (rotarine) of less than 18mm in diameter to parasites of 
10cm in length culminate into diarrhoea and determine about 5 million 
reported deaths per year.  
There are four main features, in diarrhoea, which reflect the basic underlying 
pathology and altered physiology: 
 acute watery diarrhoea 
 acute bloody diarrhoea, 
 persistent diarrhoea   
 diarrhoea with severe malnutrition of which 50% of worldwide cases of 
the condition present with watery diarrhoea.  
Approximately 35% are persistent diarrhoea and 15% dysentery-diarrhoea with 
blood stains 
Diarrhoea has been recognized as one of the most important health problems 
afflicting mankind, particularly those populations in socio-economically 
backward, and developing, third-world countries. (Gutierrez, R.M.P. et al, 
2008 ) (Venkatesan, N. et al, 2005) 
Dehydration represents the principle threat, though diarrhoea also reduces the 
absorption of nutrients, determining poor growth in children, low resistance to 
infections, and potentially long-term gut disorders.  
Annually, at least 1,500 million episodes of diarrhoea affect children under the 
age of five years and  4 million children deaths are estimated to be caused by 
diarrhoea. (WHO. http//www.who.int/aboutwho/en/preventing/preventing.htm)  
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Kung’u et al, (Kung’W. N et al, 2002) reported that 37% of all cases of 
diarrhoea in the world occur in sub-Saharan Africa. 
Morbidity and mortality due to acute diarrhea is significant even in the United 
States. (Cohen, ML.,1988) (Ho, MS, et al, 1988) The Foodborne Disease 
Active Surveillance Network (FoodNet) conducted a population-based 
telephone survey of 12,075 persons in the United States from 1998 to 1999 to 
assess diarrheal illness. Six percent reported an acute diarrheal illness at some 
point during the four weeks preceding the interview (annualized rate, 0.72 
episodes per person-year). Rates of illness were highest among children 
younger than five years (1.1 episodes per person-year) and were lowest in 
persons aged ≥65 years (0.32 episodes per person-year). (Imhoff, B. et al, , 
2004) 
In addition, Sandler and colleagues observed that the most prevalent diseases 
were non-foodborne gastroenteritis (135 million cases per year) and foodborne 
illness (76 million cases per year). (Sandler, RS et al,  2002) 
A study from England that included 9776 adults reported an incidence of 
infectious diarrhea of 19.4, 3.3, and 0.15 cases per 100 person years in a 
community cohort, those presenting to general practitioners, and cases reaching 
the national surveillance system, respectively. (Wheeler, JG et al., 1999) 
A retrospective, cross-sectional telephone survey of 3500 Canadian residents 
from February 2001 to February 2002 reported an incidence of acute 
gastrointestinal illness of 1.3 episodes per person-year. (Majowicz, SE et al, 
2004) 
The incidence of gastroenteritis was 45 per 100 person years in a prospective 
cohort study in the Netherlands involving 2206 people from the general 
population. (De Wit, MA, et al, 2000) 
A report from the Centers of Disease Control and Prevention (CDC) found that 
foodborne diseases account for approximately 76 million illnesses, 325,000 
hospitalizations, and 5000 deaths each year in the United States based upon 
surveillance data from multiple sources. While acute diarrhea occurs in most 
cases of foodborne illness, there are other causes of acute diarrhea such as  
inflammatory bowel diseases, (Mead, PS, et al., 1999) including, among others, 
Crohn’s disease (CD) and ulcerative colitis (UC).  
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In order to overcome the menace of diarrhoea in developing countries, 
especially the discomfort and inconvenience of frequent bowel movements, the 
World Health Organization (WHO) has introduced a programme for diarrhoeal 
control which involves the use of traditional herbal medicines. Several 
medicinal plants have been reported to be useful in the treatment, management 
and/or control of diarrhoea. (Abdullahi, et al, 2001) (Aniagu, S.O., et al, 2005) 
(Agunu, A., et al., 2005) 
  
ENC and gastro-intestinal tract 
 
6.1 Ileum and proximal colon 
In order to explain the pharmacological role of ENC, rich in hydrolyzable 
tannins, in the modulation of intestinal motility, its effects have been evaluated.  
Isolated guinea pig ileum and proximal colon segments were used to evaluate 
the ability of the extract to inhibit contractions evoked by agonists such as 
carbachol (CCh), serotonin (5-hydroxytryptamine [5-HT]), BaCl2, KCl and 
histamine. (Budriesi et al, 2010) 
The biological activity of ENC against CCh-induced contraction was studied in 
the isolated guinea pig ileum using papaverine as the standard reference. 
 
6.1.1 Guinea Pig Ileum 
As shown in Figure 23a, ENC reduced the maximum response to CCh in a 
concentration-dependent manner and behaved as a non competitive antagonist. 
The maximum response to carbachol was reduced in a concentration-dependent 
manner by the concentration of extract. Papaverine acts in a similar way, but its 
potency was greater.  
In guinea pig ileum, the maximum effect of ENC was reached within a 30-
minute incubation at a concentration of 1 mg/mL (Fig. 23b). The dose-response 
curve obtained with CCh after a 45-minute incubation (ENC 1 mg/mL) did not 
differ from the curve obtained after a 30-minute incubation (P < -05). 
In order to verify if the effects of ENC are reversible, we studied the 
concentration-response curves to CCh after exposure to 1 mg/mL ENC at 
different washout times. As displayed in Figure lc, the response to CCh was 
completely recovered after 60 minutes of tissue washout. 
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Figure 23. (a) Effect of ENC on carbachol (CCh)-induced contraction in isolated guinea pig ileum. 
Cumulative concentration-response curves were obtained before and after exposure to ENC for 30 
minutes. Data are mean ± SEM values (n = 5-6). (b) Time course of ENC effect on CCh induced 
contraction in isolated guinea pig ileum (100%). Cumulative concentration-response curves were 
obtained before and after exposure to ENC (1 mg/mL) for 5, 15, 30, and 45 minutes. Data are mean ± 
SEM values (n = 4-7). (c) Time course of effect of ENC (1 mg/mL) on CCh induced contraction in 
isolated guinea pig ileum. Cumulative concentration-response curves were obtained before and after 
exposure to ENC (1 mg/mL) and following washing for 5, 30, and 60 minutes. Data are mean ± SEM 
values (n = 3-5). Where error bars are not shown these are covered by the point itself 
 
The antispasmodic activity of ENC was better investigated against a variety of 
different spasmogenic agents in the guinea pig ileum. ENC reduced the 
histamine-induced spasms by a non competitive mechanism (Fig. 24a), and the 
inhibition was completely reversed after 60 minutes of tissue wash out. 
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Figure 24. (a) Effect of ENC on histamine-induced contraction of isolated guinea pig ileum. Cumulative 
dose-response curves were obtained before and after exposure to ENC (1 mg/mL) and papaverine (0.01 
mg/mL) for 30 minutes. Data are mean ± SEM values (n = 5-6). (b) Effect of ENC on KCl-induced 
contraction in isolated guinea pig ileum. Cumulative dose-response curves were obtained before and after 
exposure to ENC (1 mg/mL) and papaverine (0.01 mg/mL) for 30 minutes. Data are mean ± SEM values 
(n = 5-6). Where error bars are not shown these are covered by thè point itself. (c) Effect of ENC on 
BaCl2-induced contraction in isolated guinea pig ileum. Cumulative dose-response curves were obtained 
before and after exposure to ENC (1 mg/mL) and papaverine (0.01 mg/mL) for 30 minutes. Data are 
mean ± SEM values (n = 5-6). Where error bars are not shown these are covered by the point itself.  
 
In Figure 24a, the effect of ENC (1 mg/mL) on spastic contractions induced by 
histamine is reported in comparison with that of papaverine (0.01 mg/mL). 
Both papaverine and ENC showed the same activity profile. The contraction 
induced by KC1 (Fig. 24b) was diminished by pretreatment with ENC as well 
as by pretreatment with papaverine (Fig. 24b). The effect was completely 
reversible after 60 minutes of tissue washing. In contrast, ENC (1 mg/mL) did 
not significantly affect the contraction induced by KC1, 80 mM.  
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Spasmodic contractions elicited by BaCl2 were reduced by ENC in a 
concentration-dependent manner (Fig. 24c). The effect was similar to that 
induced by papaverine and was completely reversible after tissue washout (60 
minutes). 
 
6.1.2. Guinea Pig Proximal Colon 
In the proximal colon model, the tissues were stimulated by CCh (muscarinic 
receptors) or by 5-HT (serotoninergic receptors). 
In the first series of experiments the inhibition of CCh-induced motility was 
investigated following the protocol used for the guinea pig ileum. 
Concentration-response curves to CCh were measured in the presence or 
absence of ENC (Fig. 25a), with papaverine being used as the standard 
reference. ENC showed a lower potency in the guinea pig proximal colon 
relative to that elicited in the guinea pig ileum (Table 4). Moreover, ENC 
antagonized the carbachol response in a non competitive manner, like 
papaverine, under the same experimental conditions.  
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Figure 25: (a) Effect of ENC on CCh-induced contraction in isolated guinea pig proximal colon. 
Cumulative concentration-response curves were obtained before and after exposure to 0.5, 1.0, and 1.5 
mg/mL ENC for 30 minutes. Data are mean ± SEM values (n = 5-6). (b) Time course of ENC effect on 
CCh-induced contraction in isolated guinea pig colon (100%). Cumulative concentration-response curves 
were obtained before and after exposure to 1 mg/mL tannins for 5, 15, 30, and 45 minutes. Data are mean 
± SEM values (n = 4—7). (c) Effect of ENC (1 mg/ mL) on CCh induced contraction in isolated guinea 
pig proximal colon. Cumulative dose-response curves were obtained before and after exposure to ENC (1 
mg/mL) and following washing for 5, 30, and 60 minutes. Data are mean ± SEM values (n — 3-5). 
Where error bars are not shown these are covered by the point itself. 
 
As observed in the ileum, the maximum effect was reached after 30 minutes of 
incubation (results were not significantly different from those obtained after 45 
minutes of incubation [P < .05]) (Fig. 25b). The non competitive antagonism 
was completely reversed by 60 minutes of tissue washout (Fig. 25c). 
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Table 4. Antagonist affinities, expressed as IC50 Values, in the different guinea pig gut smooth 
muscle segments. 
ENC  Papaverine  Guinea pig Gut 
Smooth 
Muscle Segments IC50
a 95% conf lim IC50a 95% conf lim 
Ileum 0.44 0.35–0.55 0.0035 0.091–0.0089 
Proximal colon 1.50 1.22–1.84 0.25 0.15–0.58 
a IC50 was expressed as mg/ml conc. and calculated from concentration-response curves (Probit 
analysis by Litchfield and Wilcoxon with n = 6–7) (Tallarida, 1987). 
 
Then, 5-HT agonist activity in guinea pig proximal colon was also investigated 
(Fig. 26). As shown in Figure 5a, 5-HT produced a double response in the 
proximal colon: the former was a fast and strong contraction, inhibited by 
atropine, probably due to acetylcholine liberation from the intramural 
parasympathetic ganglion cells; the latter was a relaxation due a direct 
stimulation of 5-HT receptors of smooth muscle cells.  
 
Figure 26: (a) Typical data chart recorded in guinea pig proximal colon stimulated by 5-HT (50 µM) 
alone and after treatment with ENC (1 mg/ml) or atropine (1 µM) in guinea pig proximal colon. Arrows 
indicate the treatments. (b) Effect of 5-HT (50 µM) on contraction or relaxation in guinea pig proximal 
colon before, and after exposure to 0.01, 0.05 and 0.1 mg/ml of ENC for 30 minutes. All data are the 
mean ± SEM (n = 3-5). (c) Effect on 5-HT-induced contraction or relaxation (50 µM) in guinea pig 
proximal colon obtained before (control) and after exposure to ENC (1 mg/ml), atropine (1 µM) and 
papaverine (0.1 mg/ml) for 30 min. Results are expressed as the mean ± SEM (n = 4-7). Where error bars 
are not shown these are covered by the point itself. 
 
ENC ability to inhibit proximal colon movements elicited by 5-HT was 
evaluated taking papaverine as the reference. Contraction elicited by 5-HT in 
proximal colon segments was inhibited by ENC in a dose-dependent manner, 
whereas the relaxation induced by 5-HT was not affected (Fig. 26a,b). The 
effects of ENC in proximal colon appeared similar to those induced by atropine 
(1 /J.M) (Fig. 26c), whereas papaverine completely blocked both contraction 
and relaxation elicited by 5-HT. The spontaneous contractions and the basal 
tone of guinea pig ileum and proximal colon were not affected by ENC 
incubation. 
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In our experimental models, the purified ENC is able to relax guinea pig ileum 
and proximal colon smooth muscle spasms induced by several mechanisms. 
The effect of the extract on contraction induced by 5-HT is very particular as 5-
HT in proximal colon elicits two contrasting actions: it induces a strong 
contraction mediated by release of acetylcholine from the intramural 
parasympathetic ganglion cells, followed by a relaxing action due to a direct 
stimulation of 5-HT receptors of smooth muscle cells. In proximal colon 
segments ENC prevents the contraction induced by 5-HT, whereas it does not 
affect the relaxing action mediated by 5-HT. This observation points out the 
selectivity of ENC, which can inhibit the cholinergic activity but does not 
interfere directly with serotononinergic receptor activation. This molecular 
mechanism could be helpful both in reducing colon contractile activity and in 
promoting the relaxing activity of 5-HT.  
The observed data indicate that ENC could be helpful in controlling diarrhea 
through its antispasmodic effects on ileum and colon segments of the intestine, 
and this action is the result of the synergic effect of ENC. In fact, ENC exerts a 
antibacterial activity against many food-borne pathogen bacteria like 
Staphylococcus aureus and Vibrio spp.. Furthermore, some compounds, 
belonging to the class of hydrolizable tannins found in ENC, have been show 
to exert a strong antiviral activity. 
 
6.2 Discussion 
Experiments performed in guinea pig ileum showed that ENC, like papaverine, 
used as the reference standard, inhibited the maximum response to CCh in a 
noncompetitive manner. Furthermore, this blockade was reversed after tissue 
washing. The restoration of basal tone of ileum tissue, by removing ENC with 
several washings, suggests this intestinal segment was not damaged as its 
spontaneous motility was maintained. ENC displayed an IC50 value (0.44 
mg/mL) lower than that of papaverine (0.0035 mg/mL). The difference in 
potency between ENC and papaverine could be partially explained by the fact 
that a phytocomplex is made up of various components containing a pool of 
substances, whereas papaverine is a well characterized chemical compound. 
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ENC produced its antispasmodic activity not only by reduction of CCh-induced 
contractions, but also by reduction of those due to histamine, KCl, and BaCl2. 
Histamine contracts the guinea pig ileum by interacting with histamine receptor 
subtypes.[Atta AH, et al., 2005] ENC antagonizes contractions evoked by 
histamine in a noncompetitive reversible manner with a lower potency respect 
than that calculated against CCh (IC50 = 0.73 mg/mL and 0.44 mg/mL, 
respectively). The spasms induced by BaCl2, an agent able to release bound 
calcium with ganglion-stimulating properties, were inhibited by the extract. 
This could be due to the reduction of smooth muscle responsiveness by 
interfering with Ca2+ availability and bound Ca2+-releasing mechanisms. ENC 
acts as a non competitive reversible antagonist, and its potency is equal to that 
measured in antagonize the effect of CCh.  
KCl depolarizes the ileum strips, resulting in spastic contractions by activation 
of voltage-dependent Ca2+ channels. (Bolton TB, 1979) 
ENC reduces KCl-induced contractions by a noncompetitive reversible 
mechanism showing a potency threefold lower than that elicited against CCh or 
BaCl2. This antispasmodic activity might involve the inhibition of voltage-
dependent Ca2+ channels. Under the same experimental conditions papaverine 
(0.01 mg/mL) induces a full spasmodic activity block. However, ENC (1 
mg/mL) does not possess a spasmolytic action and does not affect the 
contractile response induced by KC1 (80 mM). Concerning the guinea pig 
proximal colon, inhibition induced by ENC in CCh contraction is qualitatively 
similar to that induced in guinea pig ileum, but, like papaverine, ENC is less 
potent in this intestinal segment. One of the most interesting findings was the 
results obtained with ENC in guinea pig proximal colon preparation stimulated 
with 5-HT. Contractions induced by the stimulation of neuronal 5-HT receptors 
in proximal colon are mediated by the cholinergic System, whereas the 
stimulation of the intestinal smooth muscle 5-HT receptors bcauses relaxation. 
The data reported in Table 3 show that ENC, like atropine, inhibits contraction 
induced by 5-HT (50 (μM), whereas ENC does not affect the following 
relaxation. 
It could be concluded that ENC strongly interferes with the cholinergic System 
with poor or insignificant serotoninergic activity. Moreover, ENC seems to 
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modulate the bound Ca2+-releasing mechanisms and to a minor extent the 
voltage-gated calcium channels. 
In the experimental models I used, the purified ENC has been shown able to 
relax guinea pig ileum and proximal colon smooth muscle spasms induced by 
several mechanisms. 
The effect of the extract on contraction induced by 5-HT is very particular as 5-
HT in proximal colon elicits two contrasting actions: it induces a strong 
contraction mediated by release of acetylcholine from the intramural 
parasympathetic ganglion cells, followed by a relaxing action due to a direct 
stimulation of 5-HT receptors of smooth muscle cells. In proximal colon 
segments ENC prevents the contraction induced by 5-HT, whereas it does not 
affect the relaxing action mediated by 5-HT. This observation points out the 
selectivity of ENC, which can inhibit the cholinergic activity but does not 
interfere directly with serotononinergic receptor activation. This molecular 
mechanism could be helpful both in reducing colon contractile activity and in 
promoting the relaxing activity of 5-HT. In conclusion, ENC could be helpful 
in controlling diarrhea through its antispasmodic effects on ileum and colon 
segments of the intestine, and this action is the result of the synergic effect 
between the antispasmodic effect and the antimicrobial effect of ENC. (Jamroz 
D, et al., 2009) (Frankič T, et al., 2011) 
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CHAPTER 7 
 
Biological activity of ENC toward other 
gastro-intestinal tracts and toward biliary 
tract 
 
7.1 Stomach and Juneum 
The effect of the ENC in other parts of the gastro-intestinal tract has been 
investigated. In particular, its effects toward the CCh-mediated contraction has 
been investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Effect of ENC on carbachol (CCh)-induced contraction in isolated guinea pig jeunum. 
Cumulative concentration-response curves were obtained before and after exposure to ENC for 30 
minutes. Data are mean ± SEM values (n = 5-6). (b) Carbachol (CCh)-induced contraction after 30 
minutes washout . Data are mean ± SEM values (n = 3-5). Where error bars are not shown these are 
covered by the point itself 
 
ENC is able to reduce the maximum contraction induced by carbachol. The 
observed antagonism is non-competitive and it occurs in a concentration-
dependent manner. In addition, it is reversible. 
The effects toward the CCh-mediated contraction has been investigated also in 
the duodenum. 
Also in this case, a non-competitive, reversible and concentration-dependent 
antagonism towards muscarinic receptors has been observed.  
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Figure 28: Effect of ENC on carbachol (CCh)-induced contraction in isolated guinea pig s. Cumulative 
concentration-response curves were obtained before and after exposure to ENC for 30 minutes. Data are 
mean ± SEM values (n = 5-6). (b) Carbachol (CCh)-induced contraction after 30 minutes washout . Data 
are mean ± SEM values (n = 3-5). Where error bars are not shown these are covered by the point itself. 
 
The data show that natural extract of chestnut wood exerts spasmolytic effects 
in stomach, ileum, duodenum and proximal colon, by a mechanism perhaps 
involving unspecific cellular pathways. These findings, taken together with the 
antiviral, and antibacterial activities against many food-born pathogen bacteria 
like Staphylococcus aureus and Vibrio spp., (Buzzini P. et al,  2008), and 
antispasmodic properties of tannins, suggest that tannins may be relevant to 
treat diarrhea. 
 
7.2 Biliary tracts 
The usual inhibitors of gut peristaltic contraction, such as loperamide, in 
addition to reducing the ileal and colonic motor function, inhibit the 
gallbladder motility, probably through an indirect cholinergic mechanism. 
(Hopman WP et al, 1990) 
A decrease of the gallbladder motility determines a reduction of the bile flow; 
this effect, in patients suffering from ilnesses predisposing to gallbladder 
motility alterations, increases the risk of cholelithiasis. (Thimister PW et al, 
1997) 
 
7.3 Gallstones: an increasing health trouble 
Gallstone disease represents one of the most frequent and expensive digestive 
diseases in developed countries, as its prevalence in adults ranges from 10% to 
15% (Portincasa P. et al 2006) (Wang DQH et al, 2004) (Everhart JE, et al, 
1999) (Sandler RS, et al, 2002). Many patients with gallstones remain “silent”; 
about a third of patients develop the symptoms and/or the complications. In the 
United States, medical expenses for the treatment of gallstones exceeded $6 
billion in the year 2000. Furthermore, the prevalence of gallstones seems to be 
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increasing and about one million new cases are discovered each year (Liver 
Disease Subcommittee of the Digestive Disease Interagency Coordinating 
Committee. Action Plan for Liver Disease Research. Bethesda: NIH; 2004. p. 
145-50). 
Approximately, 75% of the gallstones in the United States and westernized 
countries, including Italy, are cholesterol gallstones (Diehl AK., 1991) (Attili 
AF. et al, 1995) (Attili AF, et al., 1997). The remaining gallstones, represented 
by pigment stones which have less than 30% cholesterol by weight, can be 
subclassed into two groups: black pigment stones (about 20% of all gallstones, 
found in the gallbladder and/or bile duct, containing mainly insoluble bilirubin 
pigment polymer mixed with calcium phosphate and carbonate, and 
cholesterol) and brown pigment stones (about 5% of all gallstones, found 
mainly in bile ducts, containing calcium bilirubinate, calcium palmitate, and 
stearate and cholesterol)(Sherlock, S. et al., 2002). 
Cholesterol gallstones are associated with well known risk factors, such as 
obesity, type 2 diabetes, dyslipidaemia, and hyperinsulinaemia (Portincasa P, et 
al., 2006) (Grundy SM., 2005) (Grundy SM, et al., 2005) (Eckel RH, et al., 
2005) (Tsai CJ, et al., 2004). Furthermore, fibrates, such as gemfibrozil, 
bezafibrate, fenofibrate, clofibrate, clinically used as hypolypidemic agents,  
are shown to augment significantly the risk of gallbladder stones formation by 
increasing  the lithogenicity of bile. (Caroli-Bosc FX, et al., 2001)  (Leiss O, et 
al.,  1986) (Liang CC, et al., 2011) 
Cholesterol cholelithiasis is prevalent in populations used to consume a 
“Western” diet (i.e. enriched in saturated fatty acids, cholesterol, and rapidly 
absorbed refined carbohydrates), rather than a more “prudent” diet (i.e. 
enriched in monopolyunsaturated fats, fruit, vegetables and low in refined 
carbohydrates) associated with physical activity (Tsai CJ, et al., 2004) (Tsai 
CJ. et al., 2004) (Tsai CJ, et al., 2006) (Tsai CJ, et al., 2004) (Tsai CJ, et al., 
2005) (Leitzmann MF, et al., N Engl J Med 1999;341(11):777–84) (Tsai CJ, et 
al.,  Ann Intern Med 2004;141(7): 514–22) (Leitzmann MF. et al., 1998). 
Thus, the prevalence of cholesterol gallstone disease is significantly higher in 
North and South American as well as European populations than that in Asian 
and African populations (Diehl AK., 1991). In China, the prevalence of 
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cholesterol gallstones appears to increase with the “westernization” of the 
traditional Chinese diet (Zhu X, et al., 1995) (Huang YC, et al., 1984) (Sun H, 
et al.,  2009). Even in Japan, the adoption of Western-type dietary habits has 
resulted in a marked increase of the prevalence of cholesterol cholelithiasis 
over the past 40 years (Nakayama F, et al.,  1970) (Nagase M, et al., Am 1978). 
The complex pathogenesis of cholesterol gallstones depends on the concurrent 
existence of hepatic hypersecretion of cholesterol into bile leading to bile 
supersaturation with cholesterol, accelerated nucleation/crystallization of 
cholesterol in gallbladder bile, impaired gallbladder motility leading to 
gallbladder stasis, and increased cholesterol availability from the small 
intestine, as well as LITH genes and genetic factors (Wang HH, et al.,  2008) 
(Portincasa P, et al., 2008). 
A complex genetic basis plays a key role in determining individual 
predisposition to develop cholesterol gallstones in response to environmental 
factors (Wittenburg H, et al., 2007) (Wang DQH, et al., 2005) (Lammert F, et 
al., 2005)  
 
7.4 ENC effects towards gallbladder 
ENC has shown significant effects on promoting gallbladder contraction. In 
addition, it is able to relax Oddi sphincter. These effects may be the basis of 
treating acute pancreas adenitis. In this experiment, we found that ENC 
significantly increases the resting tension and contractile frequency of isolated 
guinea pig gallbladder strips. Neither atropine(10-8 M), nor SR27897 (10-8 M) 
reduces the ENC-mediated gallbladder contraction, suggesting that neither 
muscarinic nor CCK-1 receptors are involved in the observed activity. The 
latter action is inhibited by nicardipine, leading to suppose the involvement of 
calcium channels in the observed activity. 
The gallbladder contraction and the relaxing effect toward Oddi’s Sphincter 
occur also in guinea pigs fed a lithogenic diet, suggesting that ENC may be 
useful also in subjects at high risk of developing gallstones-such as patients 
affected by metabolic syndrome- who already have pathological alterations of 
gallbladder which may reduce its physiological contractility. 
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Furthermore, the prokinetic effect of ENC toward gallbladder has been tested 
in human gallbladder obtained from patients undergoing laparoscopic 
cholecystectomy for acute cholecystitis secondary to gallstone disease. The 
results indicate that ENC shows a contractile activity also in human 
gallbladder. In particular it has been shown that the contractile effect of ENC is 
more potent in women than in men, even if more samples are needed to 
complete this study. 
Since there are no drugs able to contract the gallbladder, the identification of a 
novel compound able to determine gallbladder contraction is very interesting. 
Also oral contraceptives are shown to favor gallstone formation. (Khan MK, et 
al., 2007) 
In these particular conditions, a substance which stimulates the contraction of 
gallbladder may be useful for the prevention of gallstones formation thus it 
may avoid the cholecystectomy. 
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Figure 29 Effect of atropine on carbacol-induced contraction of isolated guinea gallbladder. Cumulative 
dose-response curves were obtained before (  ) and after exposure to atropine 10-8 M alone and in 
presence of Castanea Sativa Mill. extract (1.0 mg/ml) for 30 min. Each point is the mean ± SEM (n = 5-
6). Where error bars are not shown these are covered by the point itself. 
 
Carbachol determines a contraction of gallbladder smooth muscle, as shown in 
fig. 29. The competitive antagonism of atropine is not affected by the presence 
of ENC, at the concentration of 1 mg/mL. The Atropine pA2 is not 
significantly affected by ENC. 
As ENC is able to affect the calcium flow through the membrane, it has been 
conducted a series of experiments where gallbladder has been depolarized 
through KCl, 80 mM. The contraction induced by KCl, 80 mM, is not altered 
by the presence of ENC. Nicardipine, a calcium antagonist, reduces the 
contraction mediated by carcbachol, in a concentration-dependent manner. 
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Figure 30. Antispasmodic activity. Effect of Nicardipine on KCl-induced contraction on isolated guinea 
gallbladder. Cumulative concentration–response curves were obtained before and after exposure 
nicardipine for 30 min. Data are mean ± SEM values (n = 5–6). Where error bars are not shown these are 
covered by the point itself. 
 
The effect of nicardipine on ENC-induced contraction has been evaluated. 
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Fig. 31. Spasmolitic activity. Effect of Nicardipine on KCl-induced contraction on isolated guinea 
gallbladder. Cumulative concentration–response curve was obtained after exposure to 80 mM of KCl for 
60 min (tempo necessario a rendere la contrazione costantez). Data are mean ± SEM values (n = 5–6). 
Where error bars are not shown these are covered by the point itself. 
 
The contraction induced by ENC at the concentration of 1 mg/mL has been 
compared with the contraction induced by different agonists such as carbachol 
(cholinergic agonist), KCl (Calcium opener), A71623 (CCK1 agonist).  
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Fig. 32. Effect of ENC induced contraction on isolated guinea gallbladder compared with those induced 
by CCh, KCl, and A71623. Data are mean ± SEM values (n = 5–6). Where error bars are not shown these 
are covered by the point itself 
 
As shown in table 5, we have calculated the potency of the contractile action 
versus gallbladder of ENC. 
 
Table 5:                   
 
Comp Gallbladder Activitya EC50 of Activity 
 Activity 
(M ± SEM) 
EC50b 
(µM) 
Activity 
(M ± SEM) 
ENC 88 ± 1.6 0.032 0.018−0.054 
a Increase in developed tension on isolated guinea-pig gallbladder at 10-4 M, expressed as percent 
changes from the control (n = 5-6). b Calculated from concentration-response curves (Probit analysis by 
Litchfield and Wilcoxon [Tallarida 1987] with n = 6-7). 
 
In the figure 20, the concentration-dependent curves of gallbladder contraction 
induced by ENC, carbachol and KCl. 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: Typical tracing of the contractile response to ENC. Each point is the mean ± SEM (n = 5-6).  
 
In order to understand the possible mechanisms involved in ENC-induced 
gallbladder contraction, we have made some experiments, where we have 
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injected the antagonists, such as atropine (muscarinic antagonist) or SR27897 
(CCK1 receptor antagonist) into the organ solution before injecting the ENC (1 
mg/mL). Since neither atropine (10-8 M) nor SR27897 (10-8 M) affect the 
gallbladder contraction, neither muscarinic receptors nor CCK1-receptors are 
involved in the ENC-mediated gallbladder contraction. 
 
 
Fig. 34. a) Effect of atropine on ENC (1.0 mg/ml)-induced contraction of isolated guinea gallbladder. 
Curves were obtained before and after exposure to atropine 10-8 M for 30 min. b) Effect of SR 27897 on 
ENC (1.0 mg/ml)-induced contraction of isolated guinea gallbladder. Curves were obtained before and 
after exposure to SR 27897 10-8 M for 30 min. Each point is the mean ± SEM (n = 5-6). Where error bars 
are not shown these are covered by the point itself. * P < 0.05 versus controls 
 
Since this contraction is inhibited by nicardipine, we suppose the contractile 
mechanism involves the calcium channels.  
Since the cholecystokinetic activity is clinically useful in those clinical 
conditions which predispose to gallstones formation, favouring the bile flow, 
we have evaluated the activity of ENC towards Oddi’s sphincter smooth 
muscle. 
7.5 Effects of ENC toward Oddi’s sphincter smooth muscle 
Sphincter of Oddi dysfunction (SOD) refers to an abnormality of Sphincter of 
Oddi (SO) contractility. It is a benign, noncalculous obstruction to flow of bile 
or pancreatic juice through the pancreaticobiliary junction, i.e., the sphincter of 
Oddi. SOD may be manifested clinically by pancreaticobiliary pain, 
pancreatitis, or deranged liver function tests. It is actually made up of two 
entities. SO dyskinesia refers to a primary motor abnormality of the SO which 
may result in a hypotonic sphincter but more commonly, a hypertonic 
sphincter. In contrast, SO stenosis refers to a structural alteration of the 
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sphincter, probably from an inflammatory process with subsequent fibrosis. 
Because it is often impossible to distinguish patients with SO dyskinesia from 
those with SO stenosis, the term SOD refers to both groups of patients. Also 
papillary stenosis, ampullary stenosis, biliary dyskinesia, and post-
cholecystectomy syndrome refers to SOD, even if the gallbladder can be intact.  
SOD occurs most after cholecystectomy, but it can occur also when gallbladder 
is present in situ. (Stuart Sherman, et al., 2001) The integrity of the relaxation 
function of the sphincter of Oddi is a prerequisite for normal delivery of bile 
into the duodenum. Sphincter of Oddi relaxation is mainly executed by non-
adrenergic, non-cholinergic NANC nerves that are essentially nitrergic in 
several species including guinea pigs and rabbits. (Szilvassy Z, et al., 1998) 
(Szilvassy Z, et al.,  1996) The therapeutic approach in patients with SOD is 
intended to reduce the resistance of the SO to the flow of bile or pancreatic 
juice. (Cheon YK, et al., 2009)  
In figure 22, it is shown the Oddi’s sphincter smooth muscle contraction in 
response to carbachol and to KCl. As shown in the same figure, ENC 
determines a relaxation.  
 
Figure 35. Effect after exposure for 30 minutes of CCh (0.1 µm), KCl (80 mM) and to ENC (1 mg/mL) 
on contraction or relaxation in guinea pig Oddi sphinter. Data are mean ± SEM values (n = 4–7). Where 
error bars are not shown these are covered by the point itself 
 
In order to investigate the effects of ENC towards gallbladder and Oddi’s 
sphincter smooth muscle in pathological conditions. 
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7.6 Guinea Pigs fed a lithogenic diet 
The administration of a lithogenic diet in guinea pigs, for a 28 days period, 
determines gallstones formation. In this condition gallbladder smooth muscle is 
altered. (Chen Q, et al., 1999) (Portincasa P, et al., 2004) 
 
 
 
Fig 36: Gallbladder and liver of guinea pigs fed a normal diet and a lithogenic diet.     
 
The gallbladder from these guinea pigs has been tested with ENC for its ability 
to determine contraction also in pathological conditions. 
The obtained results indicate that ENC is able to contract the pathological 
gallbladder with a similar potency to the contraction of a non pathological 
gallbladder. 
The same experiment has been exerted with Oddi’s Sphincter. Also in this case 
the biological activity of ENC is maintained. 
 
 
Figure 37. Effect of ENC on isolated guinea oddi sphinter. Cumulative dose–response curve was 
obtained to ENC Data are mean ± SEM values (n = 5–6).  
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Since gallbladder contraction represents a very important activity in order to 
prevent gallstones formation and there are no drugs able to exert this effect, we 
decided to investigate the effects of ENC towards human gallbladder 
contraction, using strips of gallbladder, taken from patients with with 
gallstones, surgically removed by laparoscopic cholecystectomies.  
7.7 Effects of ENC towards human gallbladder 
 
 
 
Figure 38: Cholecistocynetic activity of ENC towards human gallbladder contraction 
taken from woman (pink) and from men (blue)  
 
 
ENC is able to contract also human gallbladder and that this action is more 
accentuated in woman than in men, and it is more evident in young patient than 
in older patients.  
As this action can be clinically useful, the process towards the identification of 
the active compounds has been started.  
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CHAPTER 8 
 
ENC Fractionation 
8.1 Single Fractions Activity towards gallbladder 
contraction in guinea pigs 
 
Fractionation through solvents with an increasing polarity 
 
 
 
 
 
 
 
 
 
 
 
 
 
Butanolic Fraction Ethylacetate 
Fraction 
Water Fraction 
Figure 40: Contraction of gallbladder induced by butanolic fraction (0,1 mg/mL). compared with 
the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM values (n = 
4–7). Where error bars are not shown these are covered by the point itself 
 
Figure 41: Contraction of gallbladder induced by EthylAcetate  fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM values 
(n = 4–7). Where error bars are not shown these are covered by the point itself 
 
Figure 39: Fractionation of ENC through solvents qith an increasing polarity 
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All these fractions have been testes for their ability to contract gallbladder 
smooth muscle. For each fraction, it has been reported the comparison with 
carcachol and ENC. None of these fractions showed a higher potency than 
ENC.  
It has been exerted a fractionation through flash chromatography.  
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Figure 42: Contraction of gallbladder induced by Water  fraction (0,1 mg/mL). compared with the 
contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM values (n = 4–
7). Where error bars are not shown these are covered by the point itself 
 
Figure 43: Fractionation of ENC through Flash Chromatography 
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A preliminary analysis of some fractions has been carried out, through the 
mass spectrometry analysis, in order to observe the possible presence of some 
ellagitannins, comparing it with the already published mass spectra of 
ellagitannins from chestnut wood. 
8.2 Effects of ENC fractions towards gallbladder 
smooth muscle motility 
The single fractions, have been tested for their ability to contract gallbladder. 
 
Figure 45: Contraction of gallbladder induced by 35-36-24-s fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM 
values (n = 4–7). Where error bars are not shown these are covered by the point itself 
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Figure 44: Further fractionation of ENC through Flash Chromatography 
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Figure 46: Contraction of gallbladder induced by 21-30-24-s fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM 
values (n = 4–7). Where error bars are not shown these are covered by the point itself. 
 
 
 
 
 
Figure 31: Contraction of gallbladder induced by 8-20-24-s fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM 
values (n = 4–7). Where error bars are not shown these are covered by the point itself 
 
These findings lead us to suppose that the active fraction does not contain 
ellagitannins. 
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Figure 47:Contraction of gallbladder induced by 11-17-19-s fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM 
values (n = 4–7). Where error bars are not shown these are covered by the point itself 
 
 
 
 
Figure 48: Contraction of gallbladder induced by 9-10-19-s fraction (0,1 mg/mL). compared 
with the contraction induced by CCh (10-8M) and ENC (0,1 mg/mL). Data are mean ± SEM 
values (n = 4–7). Where error bars are not shown these are covered by the point itself 
 
8.3 Mass Spectra analysis 
Mass spectra analysis have been exerted in order to compare the mass spectra 
of the fractions with the mass spectra of ellagitannins to observe the possible 
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presence of structures with masses analogue to those of ellagitannins present in 
several chesnut wood extracts. 
The results indicate the presence of some structures with the same masses of 
vescalagina, castalagina, vescalin, castalin, ellagic acid. 
Further procedures are required in order to further separate the fractions and to 
exert several chemical analysis in order to identify the chemical structures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. 49 Mass Spectra 21-30-24s 
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Fig. 50 Mass Spectra 21-30-24s 
Fig. 51 Mass Spectra 21-30-24s 
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Fig. 53 Mass Spectra 21-30-24s 
Fig. 52 Mass Spectra 21-30-24s 
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Fig. 54 Mass Spectra 21-30-24s 
Fig. 55 Mass Spectra 21-30-24s 
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Conclusions 
 
ENC exerts many different biological acivities which may rend this extract a 
potential food supplement able to contribute to prevent some cardiovascular 
diseases and to contribute to the improvent of the health state in subjects 
suffering from cardiovascular diseases. 
It can be interesting to identify the active molecule(s) able to exert the negative 
chronotropic and positive inotropic effects. 
As regards the gastro-intestinal system, the ENC is able to reduce the 
peristalsis in different tracts, such as stomach, jeunum, ileum, colom, 
suggesting its potential role as coadjuvant in the tratement of diarrhoea. The 
cholecistokinetic action occurs in healthy guinea pigs, in guinea pigs fed a 
lithogenic diet and in human gallbladders taken from patients suffering from 
colelithiasis. The latter action is very interesting and together with the Oddi’s 
sphincter relxing effect may be useful for the prevention of colelithiasis. 
As there are no drugs able to contract gallbladder smooth muscle, the process 
leading to the identification of the active compound(s) has been started and we 
concluded and the active fraction has been identified. 
As in this fraction the preliminary analysys through mass spectra suggest that it 
does not contain ellagitannins, we hypotized that ellagitannins do not represent 
the main active compounds. 
Since vescalagin, castalagin, vescalin, castalin have been found to be present in 
ENC, we have compared the mass spectra of the ENC fractions with those of 
these ellagitannins published by  M. Sanz and colleagues (Sanz M. et al., 2010) 
The fact that in 21-30-24s the peaks of vescalagin, castalagin, vescalin and 
castalin are present lead to suppose that these molecules may be present in this 
fraction.  
Further fractionations and molecular analysis are needed to confirm this 
hypotesis.  
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Material and Methods 
 
ENC (supplied by SilvaTeam, San Michele di Mondovì, Italy) obtained by low 
pressure heating treatment. The water-soluble fraction is retained and 
subsequently dehydrated. The fine brown powder (92-95% dry matter) contains 
77% of pure tannin on a dry matter basis. The chemical composition of thè 
ENC batch used in thè experiments was as follows: water, 2.9%; tannin, 
77.8%; non-tannin, 17.7% (oligosaccharides, salts, vegetable resins, and gums 
coming from thè hydrolysis process of chestnut wood); insoluble, 1.6%; crude 
fibers, 0.24%; ash, 1.7%. The tannin percentage was obtained by gravimetrie 
analysis of vegetable tanning agents by using thè filler Freiberg-Hide powder 
method. 
Guinea pigs of either sex (200-400 g) obtained from Charles River (Calco, 
Como, Italy) were used. The animals were housed according to the ECC 
Council Directive regarding the protection of animals used for experimental 
and other scientific purposes. Ali procedures followed the guidelines of thè 
Animal Care and Use Committee of the University of Bologna (Bologna, 
Italy). The animals were sacrificed by cervical dislocation, and the organ 
(ileum and proximal colon) required was set up rapidly under a suitable resting 
tension in a 15-mL organ bath containing appropriate physiological salt 
solution consistently warmed (see below) and buffered to pH 7.4 by saturation 
with 95% O2/5% CO2 gas. 
 
Guinea pig ileum 
The terminal portion of the ileum (3-4 cm near thè ileocecal junction) was 
cleaned, and segments 2-3 cm long of ileum were set up under 1 g of tension at 
37°C in organ baths containing Tyrode's solution of the following composition: 
118mM NaCl, 4.75 mM KC1, 2.54 mM CaCl2, 1.20mM MgSO4 • 7H2O, 1.19 
mM KH2PO4 • 2H2O, 25 mM NaHCO2, and 11 mM glucose. When BaCl2 was 
used as the agonist, MgSO4-7H2O was replaced by MgCl2-6H2O. The two 
segments obtained (2-3 cm) were set up under 1 g of tension in the longitudinal 
direction along the intestinal wall. Tissues were allowed to equilibrate for at 
least 30 minutes, during which time thè bathing solution was changed every 10 
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minutes. Concentration-response curves were constructed by cumulative 
addition of the agonist (CCh, histamine, KC1, and BaCl2). The concentration 
of agonist in the organ bath was added only after the response to the previous 
addition had attained a maximal level and remained steady. Contractions were 
recorded by means of a displacement transducer (model FT 03, Grass 
Instruments, Quincy, MA, USA) using Power Lab software (ADInstruments 
Pty. Ltd., Castle Hill, NSW, Australia). In any cases, parallel experiments in 
which tissues did not receive any antagonist were run in order to check for any 
variation in sensitivity. Concentration-response curves to agonist were obtained 
at 30-minute intervals, with the first one being discarded and the second one 
being taken as the control. Following incubation with the antagonist (ENC and 
papaverine), a new concentration-response curve to agonist was obtained. 
Guinea pig proximal colon 
Starting approximately 1 cm distal from the cecocolonic junction, two 
segments of about 1 cm of the guinea pig proximal colon were cut. The 
proximal colon was cleaned by rinsing it with De Jalon solution of thè 
following composition: 155 mM NaCl, 5.6 mM KC1, 0.5 mM CaCl2, 6.0 mM 
NaHCO3, and 2.8 mM glucose. Then the mesenteric tissue was removed. The 
two segments were suspended in organ baths containing gassed, warm de Jalon 
solution under a load of 1 g maintained at 37°C. Tension changes in 
longitudinal muscle length were recorded. Tissues were allowed to equilibrate 
for at least 30 minutes, during which time the bathing solution was changed 
every 10 minutes. 
Concentration-response curves to agonist (CCh) were recorded isotonically and 
obtained at 30-minute intervals, with the first one being discarded and the 
second one being taken as the control. Following incubation with the 
antagonists (ENC and papaverine), a new concentration-response curve to 
agonist was obtained. Some experiments were performed using 5-HT as the 
agonist. Noncumulative dose-response curves to 5-HT were obtained also in 
the presence of 1 μM atropine. Longitudinal muscle contractions or relaxations 
were recorded isotonically by the mean of the Grass Instruments FT 03 force 
displacement transducer using Power Lab software. In all cases, parallel 
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experiments in which tissues did not receive any antagonist were run in order 
to check for any variation in sensitivity.  
Determination of dissociation constants 
In functional experiments, antagonism activity against different agonists of 
ENC was estimated by determining the concentration of the non competitive 
antagonist that inhibited 50% (IC50) of the maximum response to the agonist. 
Three different antagonist concentrations were used, and each concentration 
was tested at least four times. A pharmacological computer program was used 
to analyze data. A P value of < .05 was considered significant. All the figures 
were created by using GraphPad (La Jolla, CA, USA) software.  
 
Guinea pig gallbladder. Cholinergic (muscarinic receptor) activity. The 
gallbladder was removed, opened and washed several times in Krebs solution 
to remove bile. Two strips of each gallbladder approximately 0.5 cm wide X 
1.5 cm long were mounted in organ baths containing Krebs solution (15 ml) of 
the following composition (mM): NaCl, 118; KCl, 4.7; CaCl2, 2.5; 
MgSO4·7H2O, 1.2; KH2PO4·2H2O, 1.2; NaHCO2 24.9; glucose 11.1; 
maintained at 37 °C and gassed with 95% O2 and 5% CO2. A resting pre-load 
of 0.5 g was applied to each muscle strip which was then allowed to 
equilibrated for 1 h. During which time the Krebs solution was changed every 
20 min. Concentration-response curves were constructed by cumulative 
addition of the agonist (carbachol or ENC). [Van Rossum 1963] The 
concentration of agonist in the organ bath was added only after the response to 
the previous addition had attained a maximal level and remains steady. 
Contractions were recorded using isometric transducers (FT. 03, Grass 
Instruments, Quincy, MA) using Power Lab software (AD Instruments Pty Ltd, 
Castle Hill, Australia). 
For evaluation of antagonistic activity, following incubation with the 
antagonist (atropine or ENC) for 30 min, a new dose-response curve to agonist 
was obtained. In all cases, parallel experiments in which tissues did not receive 
any antagonist were run in order to check any variation in sensitivity. 
Guinea pig gallbladder. L-type calcium channel modulator activity. The 
gallbladder was removed, opened washed and put into Krebs-Henselait 
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solution (15 ml) of the following composition (mM): NaCl, 122; KCl, 5.4; 
CaCl2, 2.5; MgSO4·7H2O, 1.2; NaH2PO4·H2O, 1.2; NaHCO3 25; glucose 10; 
maintained at 37 °C and gassed with 95% O2 and 5% CO2 before cut into 
longitudinal strips 4 mm wide 7 mm long. The isometric tension was recorded 
by a force transducers (FT. 03, Grass Instruments, Quincy, MA) using Power 
Lab software (AD Instruments Pty Ltd, Castle Hill, Australia). 
Antispasmodic activity: After 1 hr of equilibration at resting tension of 1 g, 
which was reported to be optimal for measurement of changes in the tension of 
gallbladder strips for guinea pig [Moummi 1991], the strips were contracted 
with KCl. A cumulative dose response-curve was constructed and taken as 
control. Following incubation with the antagonist (nitrendipine or ENC) for 30 
min, a new cumulative dose response-curve was obtained. 
Spasmolitic activity: The strips were secured at one end to plexiglass hooks 
and connected via the surgical thread to a force displacement transducer (FT 
0.3, Grass Instruments Corporation) for monitoring changes in isometric 
contraction and were subjected to a resting force of 1 g and washed every 20 
min with fresh Krebs-Henselait solution for 1 h. After the equilibration period, 
guinea-pig aortic strips were contracted by washing in PSS containing 80 mM 
KCl (equimolar substitution of K+ for Na+). When the contraction reached a 
plateau (about 45 min) various concentrations of the compounds (nitrendipine 
or ENC) were added cumulatively to the bath allowing for any relaxation to 
obtain an equilibrated level of force. Addition of the drug vehicle had no 
appreciable effect on K+-induced contraction (DMSO for all compounds). All 
data are presented as mean ± S.E.M.. The IC50 were calculated from log 
concentration-response curves. [Tallarida RJ, et al., 1987] 
Experiment in calcium free solution: The guinea pig gallbladder was used to 
assess the activity of ENC on calcium free solution. Aortic strips were isolated 
and cleaned as previously described and placed in organ bath containing the 
Krebs-Henselait solution maintained at 37°C. Tissue were equilibrated for 1 h 
under an optimal tension of 1 g. After incubation with ENC for 30 min, 
addition of Ca2+ (2.5 mM) induced an increase in the contraction. 
Guinea pig gallbladder. Cholecystokin (CCK1) activity. The gallbladder was 
removed, opened and washed and put into Krebs-Henselait solution (15 ml) of 
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the following composition (mM): NaCl, 122; KCl, 5.4; CaCl2, 2.5; 
MgSO4·7H2O, 1.2; NaH2PO4·H2O, 1.2; NaHCO2 25; glucose 10; maintained 
at 37 °C and gassed with 95% O2 and 5% CO2 before cut into longitudinal 
strips 4 mm wide 7 mm long. The tissue were allowed to equilibrate under a 
resting tension of 0.5g for 1 h, during which time they were washed repeatedly. 
Isometric contractions were recorded using a force displacement transducer 
(FT 0.3, Grass Instruments Corporation) connected to a multichannel data 
acquisition system (Power Lab® software AD-Instruments Pty Ltd, Castle Hill, 
Australia). Cumulative concentration-response curves for CCK1 agonist 
(A71623) were obtained according to Van Rossum [Van Rossum 1963] in the 
absence and in presence of fixed concentration of antagonist (SR27897 or 
ENC) for 30 min before the agonist. Each tissue was exposed to one 
concentration of antagonist only. In all cases, parallel experiments in which 
tissues did not receive any antagonist were run in order to check any variation 
in sensitivity. 
 
Oddi sphincter. Cholinergic (muscarinic receptor) activity. The distal bile duct, 
from 1 cm above its junction with the pancreatic duct, through to its junction 
with the duodenum, including the sphinter of Oddi and 1 cm of contiguous 
duodenum. The isolated Oddi’s sphincter was immediately placed organ bath 
(15 ml) in oxygenated (95% O2 and 5% CO2) Krebs solution of the following 
composition (mM): NaCl, 132.5; KCl, 4.69; CaCl2, 2.12; MgSO2·7H2O, 0.6; 
NaH2PO4·H2O, 1.3; NaHCO2 16.39; glucose 7.66; maintained at 37 °C. The 
tissue was allowed to equilibrate for 60 min with Krebs solution replaced at 15 
min intervals. After equilibration the contractile response induced by charbacol 
was made with an isometric transducer (FT 0.3, Grass Instruments 
Corporation) connected to a multichannel data acquisition system (Power 
Lab® software AD-Instruments Pty Ltd, Castle Hill, Australia). After 
incubation with ENC for 30 min, a new cumulative dose-response curve to 
charbacol was made. 
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Guinea-Pig Atrial Preparations and treatments. 
Guinea-pigs (males and females, 300–400 g) obtained from Charles River 
(Calco, Como, Italy) were housed in a controlled environment with a 12:12-h 
light-dark cycle at 22°C and provided with chow diet and water ad libitum. 
Guinea-pigs were sacrificed by cervical dislocation. After thoracotomy the 
heart was immediately removed and washed by perfusion through the aorta 
with oxygenated Tyrode solution containing (mM): NaCl 136.9; KCl 5.4; 
CaCl2 2.5; MgCl2 1.0; NaH2PO4xH2O 0.4; NaHCO3 11.9; and glucose 5.5. The 
physiological salt solution (PSS) was buffered at pH 7.4 by saturation with 
95% O2 – 5% CO2 gas, and the temperature was maintained at 35 °C. The 
following isolated guinea-pig heart preparations were used: spontaneously 
beating right atria and left atria driven at 1 Hz were used. For each preparation, 
the entire left and right atria were dissected from the ventricles, cleaned of 
excess tissue, hung vertically in a 15 mL organ bath containing PSS 
continuously bubbled with 95% O2 – 5% CO2 at 35 °C, pH 7.4. The contractile 
activity was recorded isometrically by means of force transducer (FT 0.3, 
Grass Instruments Corporation, Quincy, MA, USA) using Power Lab® 
software (AD-Instruments Pty Ltd, Castle Hill, Australia). The left atria were 
stimulated by rectangular pulses of 0.6–0.8 ms duration and about 50% 
threshold voltage through two platinum contact electrodes in the lower holding 
clamp (Grass S88 Stimulator). The right atria were in spontaneous activity. 
After the tissues were beating for several min, a length-tension curve was 
determined, and the muscle length was maintained at the value which elicited 
90% of maximum contractile force observed at the optimal length. A 
stabilization period of 45–60 min was allowed before the atria were challenged 
by various agents. During the equilibration period, the bathing solution was 
changed every 15 min and the threshold voltage was ascertained for the left 
atria. Atrial muscle preparations were used to examine the inotropic and 
chronotropic activity of the Sweet Chestnut extract (0.01-10 mg/mL), dissolved 
in PSS. During the generation of cumulative concentration-response curves, the 
next higher concentration of extract was added only after the preparation 
reached a steady state. Some experiments were performed with a single extract 
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concentration (1 mg/mL). All data are reported as means ± SEM. The EC50 
values were calculated from concentration-response curves. [Tallarida 1987] 
2.6.1 Muscarinic activity. Was determined on guinea-pig spontaneously 
beating right atria. Tissues were suspended in PSS (see above) at 35 °C, pH 7.4 
and bubbled with 95% O2 – 5% CO2. Chronotropic activity was recorded 
isometrically. Tissues were stabilized for about 60 min, with changes in 
bathing solution every 15 min. Cumulative log concentration–response curves 
to the agonist Carbachol (CCh) (0.01–1 µM) was constructed. Following 
incubation with the antagonist atropine (1µM) or by simultaneous 
administration of atropine (1 µM) with extract (1 mg/ml) a new concentration–
response curve to CCh was obtained. Parallel experiments in the absence of 
antagonist were run. Following incubation with the antagonist atropine (1µM) 
in the absence or presence of Sweet Chestnut extract (1mg/ml), a new 
concentration–response curve to CCh was obtained. Parallel experiments in the 
absence of antagonist were run. One set of experiments was carried out using a 
single concentration of extract (1 mg/ml): in particular negative chronotropic 
activity was induced by a single dose of extract. Following incubation with 
atropine (1 µM) for 30 min, a new effect with Sweet Chestnut extract (1 
mg/ml) was done. 
Adrenergic activity Was determined on guinea pig left atria driven at 1 Hz. 
Tissues were suspended in PSS (see above) at 35 °C, pH 7.4 bubbled with 95% 
O2 – 5% CO2. Following a equilibration period (45 min) of during which the 
PSS was changed every 15 min, a contraction to Sweet Chestnut extract (1 
mg/ml) was performed. Following incubation with propranolol (10-6 M) for 30 
min, a new contraction to extract (1 mg/ml) was obtained. Simultaneously 
reproducibility of the contraction obtained by first to the second trials in the 
absence of propranolol (10-6 M) was confirmed.  
Guinea-Pig Left Papillary Muscle preparation.  
The left ventricular papillary muscles were rapidly isolated from the heart and 
suspended in an organ bath (15 mL )containing modified Ringer solution of the 
following composition (mM): NaCl 135; KCl 5; CaCl2 2; MgCl2 1; NaHCO3 
15; and glucose 5.5; bubbled with 95% O2-5% CO2, pH 7.4 at 35 °C in an 
organ bath. The papillary muscles were driven through a pair of platinum 
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electrodes (field stimulation) by square pulses (1Hz, 5-7ms, 50% threshold 
voltage). The developed tension was recorded isometrically. The preparation 
was equilibrated for at least 60 min before the start of experiments. The 
papillary muscle preparations were used to examine the inotropic activity of 
the extract (0.01-10 mg/mL), dissolved in PSS. During the generation of 
cumulative concentration-response curves, the next higher concentration of 
extract was added only after the preparation reached a steady state. Some 
experiments were performed with a single extract concentration (1 mg/mL). 
All data are reported as means ± SEM. The EC50 was calculated from log 
concentration-response curves. [Tallarida 1987] 
2.8 Guinea-Pig Aortic Strips preparation. 
The thoracic aorta was removed and placed in Tyrode solution containing 
(mM): NaCl, 118; KCl 4.75; CaCl2 2.54; MgSO4 1.20; KH2PO4 1.19; NaHCO3 
25; and glucose 11; equilibrated with 95% O2-5% CO2 at pH 7.4. The vessel 
was cleaned of extraneous connective tissue. Two helicoidal strips (10 mm x 1 
mm) were cut from aorta beginning from the end proximal to the heart. 
Vascular strips were then tied with surgical thread (6-0) and suspended in a 
jacketed tissue bath (15 mL) containing aerated PSS at 35 °C in a jacketed 
tissue bath. Aortic strips were secured at one end to plexiglass hooks and 
connected via the surgical thread to a force displacement transducer (FT 0.3, 
Grass Instruments Corporation) for monitoring changes in isometric 
contraction. Aortic strips were subjected to a resting force of 1 g and washed 
every 20 min with fresh PSS for 60 min. After the equilibration period, guinea-
pig aortic strips were contracted by washing in PSS containing 80 mM KCl 
(equimolar substitution of K+ for Na+) or 1 μM Noradrenaline (NA). When the 
contraction reached a plateau (about 45 min or 15 min respectively) different 
concentrations of the extract (0.01- 10 mg/mL) were added cumulatively to the 
bath allowing for any relaxation to obtain an equilibrated level of force. Some 
experiments were performed with a single extract concentration (1 mg/mL). 
All data are reported as means ± S.E.M.. The IC50 were calculated from log 
concentration-response curves. [Tallarida] 
Antioxidant and Cytoprotective Activities. 
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Cell Culture and Treatments. Neonatal cardiac myocytes were isolated as 
previously reported. [Hrelia 2002] The investigation conforms with the Guide 
for the Care and Use of Laboratory Animals published by the U.S. National 
Institutes of Health (NIH Publication 85-23, revised 1996) and approved by the 
Ethics Committee of our institution. Briefly, cells, obtained from the ventricles 
of 2-4-day-old rats, were grown until complete confluence. Cells were treated 
with different concentration of extract (1-500 μg/ml) for 24 h, and control cells 
were treated with equivalent concentrations of DMSO alone. 
2.4.2 Determination of cell viability. Cardiomyocyte viability of control and 
treated cells was measured using the MTT assay as previously reported. 
[Angeloni 2008] For the flow cytometry analysis the cells were double labelled 
with Annexin V conjugated to Phycoerythrin (Annexin V-PE) and 7-Amino-
actinomycin D (7 AAD), and immediately analyzed on a Guava EasyCyte flow 
cytometer (Guava Technologies, Hayward, CA) in accordance with the 
manufacturer's instructions as reported in [Angeloni C, et al., 2011]. The 
percentage of viable cells was reported with respect to the total number of 
cells. 
Detection of Intracellular Reactive Oxygen Species. The formation of ROS 
was evaluated using a fluorescent probe, DCFH-DA, as previously reported 
[Angeloni C, et al., 2007] Briefly, controls and treated cells were washed with 
PBS and then incubated with 5 μM DCFH-DA in PBS for 30 min. After 
DCFH-DA removal, the cells were incubated with 100 μM H2O2 for 30 min. 
Cell fluorescence from each well was measured using a microplate 
spectrofluorometer (λ excitation = 485 nm and λ emission = 535 nm). 
Intracellular antioxidant activity was expressed as the percentage of inhibition 
of intracellular ROS produced by H2O2 exposure. 
Determination of cytoprotective effect. Cytoprotection against H2O2 iduced 
cell damage was assessed using the MTT assay as previously reported. 
[Angeloni C, et al., 2008]. Control and treated cells were exposed to 100 μM 
H2O2 in PBS for 30 min after which cells were changed to a fresh culture 
medium. After 24 h, MTT was added to the medium at the final concentration 
of 0.5 mg/mL and incubated for 1 h at 37 °C. DMSO was added to dissolve the 
formazan crystals and the absorbance was measured at 595 nm using a 
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microplate reader VICTOR3 V™ Multilabel Counter. Data were expressed as 
percentage of viable cells with respect to controls times. 
Statistical analysis 
Data obtained from rat neonatal cardiomyocytes cell culture are presented as 
means ± S.D. and have been analyzed by one-way analysis of variance 
(ANOVA) followed by Dunnett’s test, and P value less then 0.05 has been 
considered significant. 
Data on atria, papillary muscle and aortic strips were analyzed by the Student’s 
t-test and presented as means ± S.E.M.. [Tallarida]. and P value less then 0.05 
has been considered significant The potency of drugs defined as EC50 was 
calculated from log concentration-response curves (Probit analysis using 
Litchfield and Wilcoxon [Tallarida] or from concentration-response curves or 
GraphPad Prism® [Motulsky H, et al., 2003a] [Motulsky H.J., Prism 5 
Statistics Guide, GraphPad Software Inc., San Diego CA, 2007, 
www.graphpad.com.]. Antagonist activity was estimated by determining the 
concentration of the non competitive antagonist that inhibited 50% of the 
maximum response to the agonist. Three different antagonist concentrations 
were used and each concentration was tested at least four. 
Spectrophotometric determination of total phenol content 
The total phenol (TP) content of tannin extract was determined by adapting the 
method used by Pirisini et al. [Pirisi et al.,  2000] After the extraction with 
methanol and a suitable dilution of the sample, TP content was determined by 
using the Folin-Ciocalteau reagent and measuring the absorbance at 750 nm 
(Shimadzu Spectrophotometer UV-VIS 1204, Kyoto, Japan). TP content was 
calculated using gallic acid for the construction of the calibration curve (r2 = 
0.9967), expressing the results as g of gallic acid/100 g of dry extract, 
designated as gallic acid equivalent (GAE)/100 g. 
HPLC-DAD-MS analysis 
The dry extract was dissolved in methanol and analysed in HPLC-DAD-MS, 
adapting the method described by Comandini et al. 2011. [Comandini et al., 
2011] Tannins and other phenolic compounds were quantified as g of ellagic 
acid/100 g of dry extract and indicated as ellagic acid equivalent (EAE)/100 g. 
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ENC fractionation  
4 grams of ENC were dissolved in methanol, coated on silica gel, and applied 
on top of a 40 × 4.1 cm silica gel column. 
Column chromatography was performed on silica gel 60A (particle size35-70 
μ) and the chromatography was eluted with the following eluent 
dichloromethane/ethyl acetate/acetone/Acetic acid (5:1:3:1). 
We collected 20 ml fractions according to thin layer chromatography (TLC) 
profiles. 
5 different fractions have been identified and named: 
1. 1-2-19-s 
2. 9-10-19-s 
3. 11-17-19s 
4. 21-30-19s 
5. 31-40-19s 
 
These fractions were evaporated under vacuum and stored in the freezer. TLC 
separations were performed on precoated silica gel 60 F254 plates. 
Visualisation of the separated bands was carried out under UV light (365 nm). 
The column was further eluited with the following eluent water/ acetone/Acetic 
acid (4:5:1), collecting 20 ml fractions according to thin layer chromatography 
(TLC) profiles. 4 fractions have been obtained and named: 
1. 1-7-24s 
2. 11-20-24s 
3. 21-30-24s 
4. 35-36-24s 
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A method able to isolate ellagitannins has been applied as described by Ignacio 
García-Estévez and colleagues. (Ignacio García-Estévez, M. et al., 2010) 
The powder of ENC has been first applied onto a Waters C-18 Sep-Pak® (500 
mg) cartridge (Millipore Corp., Milford, MA, USA), previously activated with 
methanol and equilibrated with 2.5% acetic acid in water. The first fraction 
(fraction a) was collected from the moment of the application of the sample 
onto the C-18 cartridge to the end of the loading step and during the elution 
with 5mL of 2.5% acetic acid in water. The second fraction (fraction b) was 
eluted with 5mL of ethyl acetate and the third (fraction c), with 5mL of 
methanol. Fractions a and b were evaporated under reduced pressure and re-
dissolved in 2.5% acetic acid to a final volume of 2 mL. 
Fraction c was also evaporated in order to remove methanol and was re-
dissolved in 2.5% acetic acid to a final volume of 5 mL. 
Fraction a was subsequently submitted to another fractionation in a hand-
packed Sephadex LH-20 minicolumn (10mm×30mm) previously activated 
with methanol and equilibrated with ultrapure water. In this second 
fractionation, three different eluents were employed obtaining four eluates as 
Figure 56: Fractionation of ENC through Flash Chromatography 
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follows: the first eluate (fraction 1) was obtained with 2mL of ultrapure water, 
the second (fraction 2), with 2mL of 100% ethanol (96% vol.), the third 
(fraction 3) with 1mL of 100% methanol and the last (fraction 4), with 5mL of 
100% methanol. All these eluates were evaporated under reduced pressure and 
re-dissolved in 2.5% acetic acid to a final volume of 2 mL. 
The fraction 4 contains ellagitannins and this fraction is used in order to have a 
standard to compare for the TLC analysis.  
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